PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
CONTENTS
Messages 03-08
1st Philippine ORL-HNS Congress 09
PSO-HNS Board of Trustees 2015 10
Organizing Committee 2015 11
Conference Guidelines 12
Vicinity Map 13
Floor Map 14
Pre-Congress Conferences 15
Program at a Glance 16-18
Program of Activities 19-27
Abstracts (Plenary) 28-35
Abstracts (Symposium) 36-58
Foreign Speakers’ Directory 59-60
Local Speakers’ Directory 61-62
Sponsors’ & Exhibitors’ Directory 63-68
Sponsors & Exhibitors Booth Layout 69-70
Acknowledgement 71
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
MESSAGES
BENIGNO S. AQUINO III
President
Republic of the Philippines
MAN I L A
30 November 2015
M y warmest greetings to the Philippine Society of
Otolaryngology - Head & Neck Surgery as you
hold your 59th Annual Convention and 1st
Philippine International ORL-HNS Congress.
Humanity has made much progress in the spirit of innovation and scientific inquiry: Your twin events reveal
the significance of continuing research in upholding excellence amidst today’s rapidly shifting milieu, as you
update with recent developments and further push the frontiers of the local practice of otolaryngology. May
these discussions refine your expertise and skills, and empower you to address the dynamic needs of our
people that you may lengthen our collective strides towards establishing Universal Healthcare.
The Philippines of today is a far cry from the Sick Man of Asia that it once was. Buoyed by a renewed
bureaucracy, a revitalized landscape, and a determined, productive populace, we can scale even greater
heights. Let us sustain our efforts, build upon our momentum, and soar towards the brighter, more equitably
progressive future we have long aspired for.
I wish you engaging and galvanized gatherings.
MALACAÑAN PALACE MANILA
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
MESSAGES
JANETTE LORETO - GARIN, M.D.
Secretary of Health
W armest greetings to the Philippines Society of Otolaryngology - Head and Neck
Surgery (PSO-HNS) on the occasion of your 59th Annual Convention and the 1st
Philippine International ORL-HNS Congress with the theme “#Head&Neck: Be
Connected, Otolaryngology in the Age of Information Technology.”
In This occasion, PSO-HNS hosts distinguished local and foreign experts on otolaryngology, who shall
provide delegates information on the latest innovations as well as effective tools and techniques in the
ENT practice. May the sessions and dialogues in the congress in the congress help in improving
knowledge and skills of our specialists.
May PSO-HNS achieve the objectives and intended results of this remarkable undertaking. May your
fellowship strengthen camaraderie among the members for the advancement of the society’s mission and
vision, and excellence in the profession. Congratulations and Mabuhay!
Republic of the Philippines
Department of Health
OFFICE OF THE SECRETARY
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
MESSAGES
I convey my heartfelt greetings and congratulations to the
organizers of the Philippine Society of Otolaryngology-Head
and Neck Surgery (PSO-HNS) as you hold your 59th Annual
Convention and the 1st Philippine International ORL-HNS
Congress with the theme: “#Head&Neck Be Connected: Otolaryngology in the Age of Information
Technology”.
The efforts of the PSO-HNS to work towards the goal of advancing the field of otolaryngology-head and
neck surgery through one encompassing gathering, is truly admirable. The unity displayed by members of
your organization speaks of how even in the most complex of issues in the global health milieu we can
discover our respective niches and contribute significantly in creating effective, lasting solutions.
The Philippine Medical Association (PMA) is honored to be a part of your distinguished work, and as
President, I urge you to continue harnessing, along with your knowledge and capabilities, your diligence
and passion in building healing and comforting environs for your patients. As the umbrella organization
of all medical organizations in the Philippines, the PMA shares your aspirations for the consummate
Filipino medical professional who is equipped with not only the needed wisdom or skills to heal and ease
the patient’s malady, but also of a relentless yearning to push the boundaries of science and of oneself.
May this event inspire excellence in all of you, and strengthen your core as an organization that constantly
strive for advancement and the highest standards of our profession.
I send my fondest wish for a fruitful and memorable Convention for all the delegates. Mabuhay and
Cheers!
"PMA: Empowering the Filipino Physician for Nation Building"
MARIA MINERVA P. CALIMAG, M.D., PhD, FPBA
President
Philippine Medical Association
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
MESSAGES
ARMANDO M. CHIONG JR., M.D. President
Philippine Society of Otolaryngology-Head & Neck Surgery
M abuhay! With much sincerity and pride, I am inviting
all of you to attend the 59th Annual Convention and let
us become part of history by participating in the 1st
Philippine International ORL - HNS Congress! The
theme for this year is one that is both interesting and relevant for us -
#Head&Neck: Be Connected “Otolaryngology in the Age of Information
Technology.
As we live and practice in a globalized world, experiencing numerous advances in technology and research,
we are called to continue to become relevant in such a context. It is about time to be updated of the innovative
new effective tools and techniques that can be of benefit for our patients, that can be applied in our beloved
subspecialties. As ENT practitioners we must adapt and immense ourselves with the new opportunities that
technology can provide to us. Thus, we, the members of the PSO - HNS and its associates have to make the
necessary initiatives, and attending this program will be a good first step.
Assisting us in this 1st step would be my colleague Dr. Melfred Hernandez, the overall chair of the
organizing committee. Also, the contribution and efforts of the reliable head of the subcommittees with their
respective members would be a significant factor in making this convention a huge success. Not to be
outdone are our sponsors and exhibitors that are always here to help us in our endeavours.
As a final word, I would like to express my deepest gratitude to the present Board of Trustees who have been
supportive of me during my tenure. Also, the same can be said to all my co-fellows of the PSO - HNS for your
past support in attaining and realizing the vision and objectives of the society. Thus, I would like to implore
all of you again show your support in this last major PSO - HNS program of the year, as well as my tenure as
your president. May the Lord be with us always and take care all of us!
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
RODOLFO P. NONATO, M.D.
President
Philippine Board of Otolaryngology-Head & Neck Surgery
MESSAGES
T he Philippine Board of Otolaryngology - Head and Neck Surgery greets and congratulates
the officers and organizing committee of the Philippine Society of Otolaryngology - Head
and Neck Surgery in this annual convention with the theme “#Head&Neck Be Connect-
ed, Otolaryngology in the Age of Information Technology.”
We anticipate it to be another successful event specially with the line up of high quality speakers. The
influence of information technology in our specialty cannot anymore be denied. It has become part of our
everyday life. The topics will surely be very interesting and a learning experience for the delegates
regardless of what generation one belongs.
However, I also hope every one will participate and enjoy the social events with renewal of friendship and
fellowship which customary in our annual convention.
Thank you and mabuhay.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
MESSAGES
MELFRED L. HERNANDEZ, M.D. Overall Convention Chair
PSO-HNS 59th Annual Convention
T o me it is to be called just the sharp sign, or the number sign,
or even the pound sign. But the hashtag?
(A hastag is a type of label or metadata tag used on social
network and micro blogging services, which makes it easier
for users to find messages with a specific theme or content. Users create and
use hashtags by placing the hash character (or number sign)# in front of a
word or unspaced phrase, either in the main text of a message or at the
end—Wikipedia)
I was one of the few remaining dinosaurs who did not and could not relate to the hashtagging phenomenon.
For the longest time, I resisted the enigma and the lure of it. But when I did succumb to the eventuality of it,
when I allowed myself to not resist and finally #Beconnected, it opened up a whole new world.
This hastagging world we now live in is one of interconnectivity, of universality, of bridging and shattering
barriers of time and distance and space. This year, we hope to bring this into our own little niche here at the
59th Annual Convention of the Philippine Society of Otolaryngology - Head and Neck Surgery and 1st
Philippine International ORL - HNS Congress.
Suddenly, our own little niche is not so little anymore. What with this new home - a sparklingly new,
humongous, pillar less, 3,000 square meter grand ballroom.
Welcome to the world of Otolaryngology in the Age of Information Technology.
#littlenichenotsolittleanymore #Head&Neck #BeConnected #59thpsohnsannualconvention
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
1st Philippine International ORL-HNS Congress
T he first Philippine International ORL-HNS Congress will be held from
November 30 - December 3, 2015 at the Marriott Grand Ballroom,
Newport City Complex. Being at the threshold of ASEAN integration in
2015, this congress highlights the globalized and international character of
the Filipino ENT practitioners’ training and perspective, while retaining the continuing
quest for local relevance. Topics to be covered will endeavour to emphasis emerging
trends, issues and controversies that challenge and beset the Filipino ENT specialists as
well. Opinion leaders and world renowned experts in the different sub-specialty fields of
otolaryngology - head and neck surgery will grace this historic congress in a show of
solidarity with the Philippine Society of Otolaryngology - Head and Neck Surgery, as it
looks back at its humble beginnings but leapfrogs to a great new future at par with the
world’s best.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
BOARD OF TRUSTEES 2015
BOARD OF TRUSTEES
Armando M. Chiong Jr., MD
President
Melfred L. Hernandez, MD
Vice President
Ramon V. Carmona, MD
Secretary
Elmo R. Lago, MD
Treasurer
Christopher Malorre E. Calaquian, MD
Auditor
Ruben Emil D. Henson III, MD
Nelson G. Magno, MD
Danilo A. Poblete, MD
Joel A. Romualdez, MD
Gina M. Seredica, MD
Trustees
Howard M. Enriquez, MD
Immediate Past President
Rodolfo P. Nonato, MD
President, PBO-HNS
CHAPTER PRESIDENTS
Chester Rosario J. Puño, MD
Northern Luzon
Nelson N. Magno, MD
Central Luzon
Arvin L. De Jesus, MD
Southern Tagalog
Melvin G. Berin, MD
Bicol
Camille Sidonie A. Espina, MD
Central Eastern Visayas
Herman Melvin P. Sirilan, MD
Western Visayas
J. Gabriel C. De Borja, MD
Southern Mindanao
Vincent Mark M. Jardin, MD
Northern Mindanao
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
59th ANNUAL CONVENTION ORGANIZING COMMITEE
Armando M. Chiong Jr., MD
Honorary Chair
Melfred L. Hernandez, MD
Overall Convention Chair
Christopher Malorre E. Calaquian, MD
Secretary General
SCIENTIFIC COMMITTEE BLOCK
Teresa Luisa Gloria-Cruz, MD
Chair
Christine Joy S. Arquiza, MD
Kathrina B. Aquino - Diaz, MD
Ma. Lourdes Berioso-Enecilla, MD
Arsenio Claro A. Cabungcal, MD
Samantha S. Castaneda, MD
Philip B. Fullante,, MD
Agnes T. Remulla, MD
SUBSPECIALTY COORDINATORS
AHNOP: Mamerto G. Almelor, MD
PAAUD: Howard M. Enriquez, MD
PACMFS: Joselito F. David, MD
PAFPRS: Jaime Anthony A. Arzadon IV,MD
PALP: Mary Arlene A. Bongosia, MD
PANORS: Norberto V. Martinez, MD
PAPO: Adonis B. Jurado, MD
PAR: Benjamin S.A. Campomanes, MD
PASS: Keith Romeo A. Aguilera, MD
FINANCE COMMITTEE BLOCK
Elmo R. Lago, MD
Chair
WAYS AND MEANS
Charlotte M. Chiong, MD
Chair
Ruben Emil D. Henson, MD
Manuel E. Villegas, MD
BOOTHS AND EXHIBITS
Mary Aimee S. Singson, MD
Chair
Jenny D. Catignas - Pongco, MD
Mark E. Nocom, MD
Neil B. Regino, MD
LOGISTICS & PROMOTIONS
COMMITTEE BLOCK
REGISTRATION & INVITATIONS
Robert R. Dy, MD
Chair
Danilo D. Deveza Jr., MD
Dominador Enrique E. Gomez, MD
Mary Jane S. Mallillin, MD
Romel D. Mercado, MD
Vangie S. Sumulong, MD
PHYSICAL ARRANGEMENT
Joseph Arnold R. Darvin, MD
Chair
Elmer M. Dela Cruz, MD
Oliver Glenn C. Domingo, MD
Kennard Q. Felix, MD
Aileen DS. Garcia, MD
Patrick Joseph A Prado, MD
Katrina Louise Q. Reyes, MD
Angelo Ian A. Sampelo, MD
Maria Elaine D. Villanueva, MD
DOCUMENTATION & PUBLICITY
Danilo D. Deveza Jr., MD
Chair
Rene Louie C. Gutierrez, MD
Arnelle Y. Quiambao, MD
SOCIAL EVENTS COMMITTEE BLOCK
Rebecca R. Feliciano, MD
Chair
GALA & FELLOWSHIP NIGHT
Cecile C. Capinpin, MD
Arnelle Y. Quiambao, MD
Ma. Cristina B. Viceral, MD
OPENING CEREMONIES
Alberto F. Calderon, MD
Chair
Jaime Anthony A. Arzadon, IV, MD
Leonides P. Cayetano, MD
Maria Elaine D. Villanueva, MD
SPORTS
Peter R. Jarin, MD
Chair
Ramon V. Carmona, Jr., MD
John Rodolfo D. Suan, Jr., MD
SECRETARIAT
Mia Filipina B. Mabuti
Mellissa B. Martinez
Sharon T. Barraquiel
Francisco H. Tutaan
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
CONFERENCE GUIDELINES
IDENTIFICATION CARDS
Upon registration, an attendee is given an ID
card. This must be worn at all times for
admission to the plenary and symposia
sessions and official social functions.
ID cards are color coded according to the
participants’ wit:
YELLOW Organizing Committee
Secretariat
GREEN Board of Trustee
Chapter President
PBO - HNS Director
PSO - HNS Past President
Senior Member
BLUE Delegate
RED Speaker
ORANGE Day Registrant
PURPLE Sponsor/ Exhibitor
Accompanying Person
Please approach members of the organizing
committee or the secretariat staff for
assistance.
SCIENTIFIC PROGRAM
Please read the delegates’ programme section
to get detailed information on the schedule.
Please be punctual, as sessions will commence
on time. Smoking is strictly prohibited in all
session rooms. Absolute silence is requested
throughout the speakers’ presentations. Please
switch to silent mode all hand held phones.
LUNCH & DINNER SYMPOSIA
Meal stubs will be collected by the waiters
prior to being served. Please do not lose your
stubs.
CONFERENCE SECRETARIAT ROOM
The conference secretariat room is located at
Executive 12 West, Marriott Grand Ballroom.
It will be open on November 30 - December 2,
2015, from 8:00 AM to 5:00 PM.
Convention IDs and
Meal Stubs
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
VICINITY MAP
MARRIOT GRAND BALLROOM
Newport Boulevard
Newport City Complex
Pasay City, Philippines
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
FLOOR PLAN
Plenary: Ballrooms A & B
Registration: Foyer (West)
Secretariat: Executive 12 West
Booths & Exhibits: Ballrooms C & D
Speakers’ Viewing Room: Executive 13 West
Ballroom
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
PRE - CONGRESS CONFERENCES
3RD PAR ENDOSCOPIC SINUS SURGERY COURSE: “MASTERING
THE BASICS” LECTURE & FRESH FROZEN CADAVER DISSECTION November 28 - 29, 2015
The Medical City
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
PROGRAM AT A GLANCE
5:00 AM - 7:00 AM UAP - PSO-HNS Health Wellness Activity 2015
Sponsored by: United American Pharmaceuticals Inc.
Executive Room 6 & 8 East
Marriott Grand Ballroom
7:30 AM - 5:00 PM R E G I S R A T I O N
9:00 AM - 10:45 AM O P E N I N G C E R E M O N I E S
Keynote Speaker: Hon. Maria Leonor G. Robredo
Ballrooms A & B
10:45 AM - 11:00 AM OPENING OF BOOTHS AND EXHIBITS
11:00 AM - 12:30 PM LUNCH SYMPOSIUM 1
Sponsored by: United American Pharmaceuticals Inc.
Ballrooms A & B
12:30 PM - 1:30 PM P1: Thyroid Cancer
Ballrooms A & B
1:30 PM - 2:30 PM P2: Computer-Aided Head & Neck Surgery and Updates in the
Management of Laryngeal Cancer
Ballrooms A & B
2:30 AM - 3:00 PM C O F F E E B R E A K
Sponsored by: Natrapharm Inc.
3:00 PM - 4:00 PM S1: Neck Dissection
Ballroom A
S2: NPCA
Ballroom B
4:00 PM - 5:00 PM S3: Raman Spectroscopy
Ballroom A
S4: Sinonasal & Orbital Tumors
Ballroom B
7:00 PM - 8:00 PM DINNER SYMPOSIUM 1
Sponsored by: United American Pharmaceuticals Inc.
Ballrooms A & B
8:00 - 12:00 MN GALA NIGHT
Sponsored by: PSO - HNS
Ballrooms A & B
DAY 1 (November 30, 2014, Monday)
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
PROGRAM AT A GLANCE
7:00 AM - 3:00 PM ELECTION OF PSO - HNS BOARD OF TRUSTEES
Executive 10 West
8:00 AM - 9:00 AM Free Paper Presentation 1
Executive 14 East
9:00 AM - 10:00 AM P3: Social Media
Ballrooms A & B
10:00 AM - 10:30 AM CME ACTIVITY
Executive 10 & 11 West
C O F F E E B R E A K
10:30 AM - 11:30 AM P4: Parathyroid & Salivary Gland Tumors
Ballrooms A & B
11:30 AM - 1:00 PM LUNCH SYMPOSIUM 2
Sponsored by: Hi - Eisai Pharmaceutical Inc.
Ballrooms A & B
1:30 PM - 2:30 PM S5: Apps & EMR
Ballroom A
S6: New Technologies
Ballroom B
2:30 PM - 3:30 PM S7: Laryngeal Oncology/ Vocology
Ballroom A
S8: Innovations in RPS
Ballroom 2B
3:30 PM - 4:30 PM RESIDENTS’ FORUM: Meet the Experts - Head & Neck
Ballroom B
3:30 PM - 5:30 PM FELLOWS BUSINESS MEETING
Ballroom A
4:30 PM - 5:30 PM PRO - HNS Quiz Bee
Ballroom B
5:30 PM - 7:30 PM PRE - ALUMNI NIGHT COCKTAILS
Sponsored by: Biomedis
House Manila, Remington Hotel
7:30 PM - 8:00 PM VERTIGO FORUM
The Bellevue Manila, Alabang, Muntinlupa
8:00 PM—12:00 AM ALUMNI NIGHT
DAY 2 (December 1, 2015, Tuesday)
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
PROGRAM AT A GLANCE
8:00 AM - 9:00 AM PJO - HNS Workshop
Executive 10 & 11 West
8:00 AM - 9:00 AM Free Paper Presentation 2
Executive 14 East
9:00 AM - 10:00 AM P5: Oral Cavity Cancer
Ballrooms A & B
10:00 AM - 10:30 AM C O F F E E B R E A K
10:00 AM - 11:00 AM Poster Session Contest on Surgical Innovation & Instrumentation
Executive 14 East
10:30 AM - 11:30 AM P6: Prognostication in Head & Neck Cancer
Ballrooms A & B
11:30 AM - 1:00 PM LUNCH SYMPOSIUM 3
Sponsored by: Sandoz Philippines
Ballrooms A & B
1:30 PM - 2:30 PM S9: Computer Aided Surgery
Ballroom A
S10: Pediatric ORL: JNA & Vascular
Tumors
Ballroom B
2:30 PM - 3:30 PM S11: Sleep
Ballroom A
S12: Current Concepts: COM &
Skull Base Surgery
Ballroom B
3:30 PM - 4:30 PM S13: Plastic Surgery in ORL
Ballroom A
S14: Audiology
Ballroom B
6:00 PM - 7:00 PM DINNER SYMPOSIUM 2
Sponsored by: A. Menarini Philippines Inc.
Ballrooms A & B
7:00 PM - 8:00 PM C L O S I N G C E R E M O N I E S
Ballrooms A & B
8:00 PM - 12:00 MN FELLOWSHIP NIGHT
Sponsored by: PSO - HNS
Ballrooms A & B
DAY 3 (December 2, 2015, Wednesday)
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
PROGRAM OF ACTIVITIES
5:00 AM - 7:00 AM UAP - PSO-HNS Health Wellness Activity 2015
Sponsored by: United American Pharmaceuticals Inc.
Executive Rooms 6 & 8 East
7:30 AM - 5:00 PM R E G I S R A T I O N
Sponsored by: UniCARE - United Laboratories, Inc.
9:00 AM - 10:45 AM O P E N I N G C E R E M O N I E S
Keynote Speaker: Hon. Maria Leonor Gerona Robredo
Ballrooms A & B
10:45 AM - 11:00 AM OPENING OF BOOTHS AND EXHIBITS
11:00 AM - 12:30 PM LUNCH SYMPOSIUM 1:
The Use of Oral Systemic Corticosteroid in ENT Practice
Gil M. Vicente, M.D. (Philippines)
Ruzanne M. Caro, M.D. (Philippines)
Sponsored by: United American Pharmaceuticals Inc.
Ballrooms A & B
12:30 PM - 1:30 PM PLENARY 1: Thyroid Cancer
Ballrooms A & B
Chair: Teresa Luisa Gloria-Cruz, M.D.
Co-chair: Patrick Pardo, M.D.
Thyroid Cancer - Triumph Over Butchery
Ashok R. Shaha, M.D., FACS (USA)
1:30 PM - 2:30 PM PLENARY 2: Computer-Aided Head & Neck Surgery and Updates in the
Management of Laryngeal Cancer
Ballrooms A & B
Chair: Josefino G. Hernandez, M.D.
Co - Chair: Lei-Joan S. Vital, M.D.
Computer - Aided Surgery Around the Head: 18 Years of Experience
Prof. Marco Caversaccio, M.D. (Switzerland)
Updates in the Management of Laryngeal Cancer
Alfredo Q.Y. Pontejos Jr., M.D. (Philippines)
DAY 1 NOVEMBER 30, 2015 MONDAY
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
PROGRAM OF ACTIVITIES
2:30 AM - 3:00 PM C O F F E E B R E A K
Sponsored by: Natrapharm Inc.
3:00 PM - 4:00 PM SYMPOSIUM 1: Neck Dissection
Ballroom A
Chair: Virgilio R. De Gracia, M.D.
Co-chair: Manuel E. Villegas, M.D.
Updates in the Classification of Neck Dissection
Alfredo Q.Y. Pontejos, M.D. (Philippines)
The Role of Elective Dissection in Head & Neck Cancer
Ashok R. Shaha, M.D., FACS (USA)
The Role of Therapeutic Neck Dissection in Head & Neck Cancer
Dominiek Monserez, M.D. (Netherlands)
SYMPOSIUM 2: NPCA
Ballroom B
Chair: Robie V. Zantua, M.D.
Co-chair: John V. Silva, M.D.
Salvage Nasopharyngectomy for NPCA from Open to Endoscopic
Sheng - Po Hao, M.D., FACS, FICS (Taiwan)
All That is New in Radiation Treatment of NPCA
Johanna Patricia A Cañal, M.D., MHA (Philippines)
NPCA: Updates on Management with Chemotherapy
Marlinda Adham, M.D. (Indonesia)
4:00 PM - 5:00 PM SYMPOSIUM 3: Raman Spectroscopy & Phytotherapy
Ballroom A
Chair: Emmanuel L. Ibay, M.D.
Co-chair: Mario Adrian M. Zafra, M.D.
Resection Margins in Oral Cavity Tumor & Raman Spectroscopy
Jose Angelito U. Hardillo, M.D., PhD (Netherlands)
Phytotherapy in Head & Neck Cancer
Prof. Lars Eric Pontus Stierna, M.D., PhD (Sweden)
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
PROGRAM OF ACTIVITIES
4:00 PM - 5:00 PM SYMPOSIUM 4: Sinonasal & Orbital Tumors
Ballroom B
Chair: Rhodora A. del Rosario-Ocampo, M.D.
Co-chair: Cherry Gay G. Gatchalian, M.D.
Management of Inverted Papilloma in the New Millenium
Dominiek Monserez, M.D. (Netherlands)
Conquering Conundrums in Orbital Tumors & Pseudotumors
Ma. Donna D. Santiago, M.D., MBA (Philippines)
7:00 PM - 8:00 PM DINNER SYMPOSIUM 1:
Cefuroxime: Across-the-Board Option in ORL - HNS Surgery
Teresa Luisa Gloria - Cruz, M.D. (Philippines)
Sponsored by: United American Pharmaceuticals Inc.
Ballrooms A & B
8:00 - 12:00 MN GALA NIGHT
Sponsored by: PSO - HNS
Ballrooms A & B
DAY 2 DECEMBER 1, 2015 TUESDAY
7:00 AM - 3:00 PM ELECTION OF PSO - HNS BOARD OF TRUSTEES
Executive 10 West
8:00 AM - 9:00 AM Free Paper Presentation 1
Executive 14 East
Moderator: Samantha S Castaneda, M..D.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
PROGRAM OF ACTIVITIES
9:00 AM - 10:00 AM PLENARY 3: Social Media
Ballrooms A & B
Chair: Philip B. Fullante, M.D.
Co-chair: Rodante A. Roldan, M.D.
Social Media & the Health Professionals
Iris Thiele Isip Tan, M.D., MSc (Philippines)
To Click or Not to Click: Social Media & the M.D.
Ivy D. Patdu - Calaquian, M.D., J.D. (Philippines)
10:00 AM - 10:30 AM CME ACTIVITY
Leading the Way in the Management of ENT Diseases:
Through the Years
Josefino Hernandez, M.D. (Philippines)
C O F F E E B R E A K
10:30 AM - 11:30 AM PLENARY 4: Parathyroid & Salivary Gland Tumors
Ballrooms A & B
Chair: Jacob S. Matubis, M.D.
Co-chair: Daniel M. Alonzo, M.D.
Surgical Management of Hyperparathyroidism
Ashok R. Shaha, M.D., FACS (USA)
Evaluation & Management of Parotid Tumors
Ashok R. Shaha, M.D., FACS (USA)
11:30 AM - 1:00 PM LUNCH SYMPOSIUM 2:
Simplifying LPR Diagnosis & Assessment of Therapy -
The Filipino Reflux Symptom Index
Jose Florencio F. Lapeña Jr., M.D.
Sponsored by: Hi - Eisai Pharmaceutical Inc.
Ballrooms A & B
1:30 PM - 2:30 PM SYMPOSIUM 5: Apps & ELECTRONIC MEDICAL RECORDS
Ballroom A
Chair: Rene S. Tuazon, M.D.
Co-chair: Geraldine L. Luna, M.D.
Mobile Applications for the #ConnectedENT
Philip B. Fullante, M.D. (Philippines)
EMR in the Philippines: Current State, Benefits & Challenges
Michael Hussin B. Muin, M.D. (Philippines)
Computerizing the Practice & Leveraging the Information
Jerry Rapes (Philippines)
Willex Perez (Philippines)
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
PROGRAM OF ACTIVITIES
1:30 PM - 2:30 PM SYMPOSIUM 6: New Technologies
Ballroom B
Chair: Joel A. Romualdez, M.D.
Co-chair: Franco Louie Abes, M.D.
Self Developed Robot for Cochlea Implantation: Reality or Future?
Prof. Marco Caversaccio, M.D. (Switzerland)
Possible Indications for Computer Aided Surgery on the Lateral Skull
Base
Prof. Marco Caversaccio, M.D. (Switzerland)
A New & Complete Tool for ENT Surgeons in Diagnosing OSAS
Magne Tvinnereim, M.D., PhD (Norway)
2:30 PM - 3:30 PM SYMPOSIUM 7: Laryngeal Oncology & Vocology
Ballroom A
Chair: Frederick Y. Hawson, M.D.
Co-chair: Fortuna Corazon Aberin-Roldan, M.D.
LASER Surgery for Early Stage Laryngeal Cancer
William L. Lim, M.D. (Philippines)
LASER Surgery for Management of Recurrent Laryngeal Cancer
Prof. Dr. Robert Baatenburg De Jong, (Netherlands)
Voice Care Essentials: Portable Voice Amplifier & Voice Aerobics
Mary Arlene A. Bongosia, .M.D. (Philippines)
SYMPOSIUM 8: Innovations in Rhinopharyngology
Ballroom B
Chair: Josefino G. Hernandez, M.D.
Co-chair: Ma. Lourdes B. Enecilla, M.D.
Hospital Information System for the Future: SNUBH Way
Chae-Seo Rhee, M.D. (South Korea)
Sublingual Immunotheraphy in Korea: Perspective from Rhinologists
Chae-Seo Rhee, M.D. (South Korea)
Innovations in the Diagnosis & Management of OSAS
Magne Tvinnereim, M.D., PhD (Norway)
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
PROGRAM OF ACTIVITIES
3:30 PM - 4:30 PM RESIDENTS FORUM: Meet the Experts - Head & Neck
Ballroom B
Moderators: Kirt Areis Delovino , M.D. & Jan Warren A Holgado, M.D.
Panelists:
Marlinda Adham, M.D. (Indonesia)
Prof. Dr. Robert Baatenburg De Jong (Netherlands)
Ashok R. Shaha, M.D., FACS (USA)
Sheng - Po Hao, M.D., FACS, FICS (Taiwan)
3:30 PM - 5:30 PM FELLOWS’ BUSINESS MEETING
Ballroom A
4:30 PM - 5:30 PM PRO - HNS QUIZ BEE
Ballroom B
5:30 PM - 7:30 PM PRE - ALUMNI NIGHT COCKTAILS
Sponsored by: Biomedis
House Manila, Remington Hotel
7:30 PM - 8:00 PM VERTIGO FORUM
The Bellevue Manila, Alabang, Muntilupa
8:00 PM—12:00 MN ALUMNI NIGHT
DAY 3 DECEMBER 2, 2015 WEDNESDAY
8:00 AM - 9:00 AM PJO - HNS WORKSHOP: Electronic Manuscript Submission for
Publication in the Philippine Journal of Otolaryngology-Head & Neck
Surgery: How to Submit a Manuscript and Hurdle the Peer Review
Jose Florencio F. Lapeña Jr., M.D., MA (Philippines)
Executive 10 & 11 West
8:00 AM - 9:00 AM Free Paper Presentation 2
Executive 14 East
Moderator: Samantha S Castaneda, M..D.
9:00 AM - 10:00 AM PLENARY 5: Oral Cavity Cancer
Ballrooms A & B
Chair: Mamerto G. Almelor, Jr., M.D.
Co-chair: Armando M. Chiong, Jr., M.D.
Pre - Treatment Assessment in Oral Cancer
Prof. Dr. Robert Baatenburg De Jong (Netherlands)
Contemporary Surgical Management of Oral Cancer
Sheng - Po Hao, M.D., FACS, FICS (Taiwan)
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
PROGRAM OF ACTIVITIES
10:00 AM - 10:30 AM C O F F E E B R E A K
10:00 AM - 11:00 AM Poster Session Contest on Surgical Innovation & Instrumentation
Executive 14 East
Moderator: Samantha S Castaneda, M..D.
10:30 AM - 11:30 AM PLENARY 6: Prognostication in Head & Neck Cancer
Ballrooms A & B
Chair: Daniel M. Alonzo, M.D.
Co-chair: Arsenio Claro A. Cabungcal, M.D.
Model for Prognostication in Head & Neck Cancer
Prof. Dr. Robert Baatenburg De Jong (Netherlands)
Prognostication of HPV(+) & Response to Radiotherapy for Head &
Neck Cancer
Jose Angelito U. Hardillo, M.D., PhD (Netherlands)
11:30 AM - 1:00 PM LUNCH SYMPOSIUM 3:
The Art of Healing the Nose. The Science of Breathing in Harmony
Gil M. Vicente, M.D. (Philippines)
Sponsored by: Sandoz Philippines
Ballrooms A & B
1:30 PM - 2:30 PM SYMPOSIUM 9: Computer Aided Surgery
Ballroom A
Chair: Jehan Grace B. Maglaya, M.D.
Co-chair: Joselito F. David, M.D.
Improving the Outcomes with Preoperative 3D Planning & Computer
Aided Surgery in Craniomaxillofacial Reconstruction
Francis V. Roasa, M.D. (Philippines)
Improving Outcomes with Computer Planning in Intra Operative
Navigation in Craniomaxillofacial Surgery
Ferdinand G. Pamintuan, M.D. (Philippines)
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
PROGRAM OF ACTIVITIES
1:30 PM - 2:30 PM SYMPOSIUM 10: Pediatric ORL: JNA and Vascular Tumors
Ballroom B
Chair: Adonis B. Jurado, M.D.
Co-chair: Antonio H. Chua, M.D.
Surgical Approaches to Juvenile Nasopharyngeal Angiofibroma
Lyra V. Veloro, M.D. (Philippines)
Treatment Options for Pediatric Vascular Tumors of the Head & Neck
Cecilia Gretchen S. Navarro-Locsin, M.D. (Philippines)
2:30 PM - 3:30 PM SYMPOSIUM 11: Sleep
Ballroom A
Chair: Romulus Roberto Peter A. Instrella, M.D.
Co-chair: Maria Patricia Ann T. Puno, M.D.
Wearable for Sleep Apnea
Keith Romeo A. Aguilera, M.D. (Philippines)
Effect of Head & Neck Cancer on Sleep
Jonalyn Chris T. Ang, M.D. (Philippines)
SYMPOSIUM 12: Current Concepts: COM & Skull Base Surgery
Ballroom B
Chair: Erasmo Gonzalo D.V. Llanes, M.D.
Co-chair: Joanne Sebastian M. De Ramos, M.D.
NHSRC Registry: An IT Model
Ryan Julius Bañez, M.D. (Philippines)
Telemetry Unleashed: A Singaporean Experience with Remote
Assistants in Intraoperative Neural Response Telemetry
Barrie Yau Boon Tan, M.D. (Singapore)
Cochlear Implants in Single-Sided Deafness for Sudden Sensorineural
Hearing Loss: Early Findings of a Singaporean Prospective Study
Barrie Yau Boon Tan, M.D. (Singapore)
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
PROGRAM OF ACTIVITIES
3:30 PM - 4:30 PM SYMPOSIUM 13: Plastic Surgery in ORL
Ballroom A
Chair: Cesar V. Villafuerte, M.D.
Co-chair: Jaime Anthony A. Arzadon IV, M.D.
Cutaneous Surgery
John M. Hodges, M.D., FACS (USA)
Creating a Functional Nose with Rhinoplasty
John M. Hodges, M.D., FACS (USA)
Facial Plastic Surgery Overview
John M. Hodges, M.D., FACS (USA)
3:30 PM - 4:30 PM SYMPOSIUM 14: Audiology
Ballroom B
Chair: Howard M. Enriquez, M.D.
Co-chair: Diosdado C. Uy, M.D.
Stimulus Considerations for ABR & ASSR Recording
Andre Lodwig, M.D. (Germany)
Impact of Stimulus Selection on ABR & ASSR Performance
Mr. Russell Higgs (United Kingdom)
6:00 PM - 7:00 PM DINNER SYMPOSIUM 2:
Bilastine: The Philippine Experience
Josefino G. Hernandez, M.D. (Philippines)
Margaret C. Lim - Jurado, M.D. (Philippines)
Sponsored by: A. Menarini Philippines Inc.
Ballrooms A & B
7:00 PM - 8:00 PM C L O S I N G C E R E M O N I E S
Ballrooms A & B
8:00 PM - 12:00 MN FELLOWSHIP NIGHT
Sponsored by: PSO - HNS
Ballrooms A & B
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (PLENARY)
PLENARY 1: Thyroid Cancer November 30, 2015 (12:30 - 1:30 PM)
THYROID CANCER - TRIUMPH OVER BUTCHERY
Ashok R. Shaha, M.D., FACS (USA)
There is a rapid of increase of thyroid cancer all over the world. The majority of these are
micro carcinomas on incidental findings. Several nuances have been made in the diagnostic
evaluation, with molecular markers. The debate about extent of thyroidectomy has been essentially
resolved up to 4cm as lobectomy, the choice of treatment. There continues to be considerable
debate regarding the central compartment nodal dissection, however the general consensus is to
consider selective nodal dissection with suspicious nodal involvement. The radioactive iodine is
rarely used in low risk thyroid cancer patients. The decisions about extent of thyroidectomy and
adjuvant treatment are based now on the risk group analysis. The role of external radiation
therapy is fairly well defined for better control of the local disease in the thyroid area.
Enormous progress has been made in medullary thyroid carcinoma with RET mutation and
prophylactic total thyroidectomy. Anaplastic thyroid carcinoma continues to be difficult problem
with high mortality.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (PLENARY)
PLENARY 2: Computer Aided Head & Neck Surgery & Updates in the Management of
Laryngeal Cancer November 30, 2015 (1:30 - 2:30 PM)
COMPUTER AIDED SURGERY AROUND THE HEAD: 18 YEARS OF EXPERIENCE
Prof. Marco Caversaccio, M.D. (Switzerland)
Microscopic or endoscopic skull base surgery is technically demanding and its outcome has
a great impact on a patient’s quality of life. Our research group in Bern is aimed at developing and
evaluating enabling navigation surgery tools for simulation, planning, training, education and
performance since 18 years. Other commercial products have been integrated. Clinically applied
technological research with patient series for anterior and lateral skull base procedures were
treated between 1997-2015. Optical tracking technology was used for positional sensing of
instruments. Specific designed dynamic reference base with different registration techniques using
e.g. a fine needle pointer or ultrasound, enables the surgeon to work with a target error of < 1mm.
An automatic registration assessment method, which provides the user a color-coded fused
representation of CT and MR images, indicates to the surgeon the location and extent of
registration accuracy. Additionally, guidance information (augmented reality) from multimodal
datasets (CT, PET-CT, MRI, Angiography) can be overlayed directly onto the surgical microscope
view or the endoscope. A virtual simulator as a training tool could allow in endonasal and
otological skull base surgery the understanding and preoperative practice with real-patient data in
a residency program. An improved quality of surgical outcome and satisfaction for the surgeon
was identified compared to our control group without navigation and compared to the literature.
Acknowledgments: supported by the Swiss National Science Foundation www.co-me.ch,
and ISTB www.istb.unibe.ch Prof. L.P. Nolte. www.hno.insel.ch.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (PLENARY)
PLENARY 2: Computer Aided Head & Neck Surgery & Updates in the Management of
Laryngeal Cancer November 30, 2015 (1:30 - 2:30 PM)
UPDATES IN THE MANAGEMENT OF LARYNGEAL CANCER
Alfredo Q.Y. Pontejos, M.D. (Philippines)
Modern day laryngeal cancer surgery is built upon the work of a long succession of
predecessors, from the time of Bilroth in 1873 (total laryngectomy) to Joseph Ogura
(hemilaryngectomy) in 1955 to Jako and Kleinsasser in 1966 (CO2 LASER resection).
Aside from surgery, other modalities developed particularly radiotherapy, chemotherapy,
and targeted therapy. The incidence of laryngeal cancer in the Asia-Pacific ranges from 0.6 to 6.3
per 100,000. Therefore, it carries a heavy health burden for the region.
Each country follows certain management protocols, however, the most popular would still
be the NCCN guidelines. Total laryngectomy remains to be the gold standard in the management
of laryngeal cancers specifically in stage IV cancer. In the Philippines, we follow certain guidelines.
For T1/T2 cases, radiotherapy or open/endoscopic surgery are the options. For T3 cases, options
are conservation surgery or concurrent chemotherapy and radiotherapy.
With the publication of the VA trial in 1991, there was a trend towards non-surgical
conservation management, particularly chemoradiation, and this developed to some confusion
resulting in a decrease in the overall survival of laryngeal cancer patients as shown in the SEER
reports.
There is a need therefore to come up with further researches comparing non-surgical
conservation management versus surgical management in treatment of laryngeal cancer.
Of course, personalized care is the way to go in managing our laryngeal cancer patients.
Treatment should be individualized for each patient with regards to overall patient condition,
stage of the disease, and numerous social and cultural considerations (Drago Prgomet, 2012). And
as Dr. Javier Gavilan would say, “there are no treatment of choice but rather choices of treatment.”
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (PLENARY)
PLENARY 3: Social Media December 1, 2015 (9:00 - 10:00 AM)
SOCIAL MEDIA & THE HEALTH PROFESSIONALS
Iris Thiele Isip Tan, M.D., MSc (Philippines)
TO CLICK OR NOT TO CLICK: SOCIAL MEDIA AND THE M.D.
Ivy D. Patdu-Calaquian, M.D., JD (Philippines)
Social Media is the new avenue for sharing of information. Through social media, one can
reach a global community. It has been an invaluable tool for health education and social
networking. In a world where information is power, social media occupies a unique position. The
challenge has been to use the power afforded by social media responsibly, and to define the line
between use and abuse. While there are existing laws which could serve as anchor for complaints
of those aggrieved by abuse of social media, use of social media has apparently been unregulated
because of its very nature. With one click, an opinion can become fact, and an unverified fact
becomes truth. Its extensive use has blurred the lines between professional and personal lives. The
use of social media also raises concerns for the patient’s right to privacy and the extent by which it
should be protected. In the end, medical professionals should understand that the benefits of social
media comes with an obligation. Use of social media requires a personal commitment to uphold
the ethical standards required of the medical professional, upon which patient trust is built.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (PLENARY)
PLENARY 4: Parathyroid & Salivary Gland Tumors December 1, 2015 (10:30 - 11:30 AM)
SURGICAL MANAGEMENT OF HYPERPARATHYROIDISM
Ashok R. Shaha, M.D., FACS (USA)
The incidence of parathyroid surgery has increased considerably. Hyperparathyroidism is
the 2nd most common cause of primary hyperparathyroidism. The NIH has developed guidelines
for considering surgery in asymptomatic mild hypercalcemia such as age, bone density score, etc.
Clearly the patient’s general well being improves considerably after parathyroidectomy. However,
certain patients with mild hypercalcemia can be easily treated with medication and close follow
up. There is considerable interest now in localization leading to focal surgical exploration. The best
studies for localization are Sestamibi scan, ultrasound and 4D CT scan. If the glands cannot be
identified, bilateral surgical exploration would be most appropriate.
Recently, there is a considerable interest in intraoperative quick PTH. If the PTH drops by
more than 50% and within normal limits the surgical success is excellent. Some centers use gamma
probe for intraoperative parathyroid localization with excellent surgical success, however recently
they have reverted to bilateral surgical exploration. Occasionally, a parathyroid gland may be
found intimately adherent to the thyroid gland at which time due to consideration should be given
for thyroid lobectomy as this may turn out eventually to be parathyroid cancer. Preoperative
ultrasound will also identify any thyroid abnormality in these patients and appropriate
intervention may be undertaken for thyroid nodules. The success of parathyroid surgery exceeds
95%, however the persistent hyperparathyroidism requires in detail evaluation of the diagnosis,
best localization studies and re-exploration. The majority of the hidden parathyroid glands are
behind the esophagus, in the superior mediastinum or undescended parathyroid glands. The
intraoperative PTH has revolutionized the success of parathyroid surgery.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (PLENARY)
PLENARY 4: Parathyroid & Salivary Gland Tumors December 1, 2015 (10:30 - 11:30 AM)
EVALUATION AND MANAGEMENT OF PAROTID TUMORS
Ashok R. Shaha, M.D., FACS (USA)
The majority of the parotid tumors are benign. The most common benign tumor is
pleomorphic adenoma and the most common malignant tumor is mucoepidermoid carcinoma and
adenoid cystic carcinoma. The common presentation of the salivary gland tumors is a lump in the
parotid region.
Occasionally, patients may present in advance stage with lymph node metastasis or facial
palsy. The diagnostic evaluation, appropriate imaging studies which may include CT scan or MRI.
Recently, there is an interest in ultrasound and ultrasound guided needle biopsy. Needle biopsy is
an important investigation to rule in salivary gland pathology versus non-salivary pathology.
However, it fails to distinguish accurately between benign or malignant tumor. The majority of the
patients with salivary gland tumors will require surgical intervention. Certain benign conditions
such as pleomorphic adenoma or Warthin’s tumor may be observed, specially in patients with
co-morbidities.
The most appropriate surgical intervention includes superficial parotidectomy. There
appears to be considerable interest in partial parotidectomy with identification and preservation of
the lower division of the facial nerve, The entire parotid surgery revolves around injury to the
facial nerve. The operating surgeon should be familiar with the anatomy and recognition of the
facial nerve appears to be directly involved by the tumor it would require appropriate sacrifice and
reconstruction. The postoperative adjuvant radiation therapy is used for high risk parotid tumors
where stage is more important than grade of the tumor. There is some interest in use of neutron
therapy as a primary treatment in patients with advance salivary gland tumors. Occasionally, the
patient may present with minor salivary gland tumors involving the sinuses, base of the tongue or
upper aerodigestive tract.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (PLENARY)
PLENARY 5: Oral Cavity Cancer December 2, 2015 (9:00 - 10:00 AM)
PRE-TREATMENT ASSESSMENT IN ORAL CAVITY
Prof. Dr. Robert J. Baatenburg De Jong (Netherlands)
CONTEMPORARY SURGICAL MANAGEMENT OF ORAL CANCER
Sheng-Po Hao, M.D., FACS, FICS (Taiwan)
Oral cavity cancer is a global issue, especially in the Asia-Oceania regions. The contemporary
management of oral cancer can be focused on the following principles:
1. Management of Oral Potential Malignant Disorders (OPMD): prevention, screening,
diagnosis and malignant transformation detection and chemoprevention.
2. Surgical principals: extend of resection, functional preservation of surgical approaches,
appropriate reconstruction
3. Paradigm shift in surgical approach, from open to endoscopic
4. Neck dissections: elective versus therapeutic
5. Clinicopathological parameters, prognosticators
6. Adjuvant combined chemoradiation therapy
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (PLENARY)
PLENARY 6: Prognostication in Head & Neck Cancer December 2, 2015 (10:30 - 11:30 AM)
MODEL FOR PROGNOSTICATION IN HEAD & NECK CANCER
Prof. Dr. Robert J. Baatenburg De Jong (Netherlands)
PROGNOSTICATION OF HPV(+) & RESPONSE TO RADIOTHERAPY FOR HEAD &
NECK CANCER
Jose Angelito U. Hardillo, M.D., PhD (Netherlands)
Human papillomavirus (HPV) associated head and neck squamous cell carcinoma
(HNSCC), particularly oropharyngeal squamous cell carcinoma (OPSCC), are characterized by a
significant survival advantage over their HPV-negative counterparts. Although the reasons behind
this are still not fully elucidated, it is widely accepted that these tumors have a higher response to
ionizing radiation that might explain their favourable outcomes. In Rotterdam, oropharyngeal
carcinomas are treated mainly with locoregional radiotherapy, 46 GY using IMRT, followed by a
local boost using cyberknife or brachytherapy and neck dissection for clinically N+ cases. In a
recent review of 92 N+ cases treated between 1999-2012, 70% were positive for p16 (p16+). 34% had
a full downstaging of N status (pN0) after 46 Gy using IMRT while another 20% had a partial
downstaging of N status. Although not significant, p16+ tumors have an odds ratio of 3.26 in
achieving full downstaging of N status after IMRT.
Tumors with full regional control (pN0) after IMRT have significantly better survival. P16+
tumors had significantly better overall 5 year and disease free survival than p16– tumors.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 1: Neck Dissection Ballroom A November 30, 2015 (3:00 - 4:00 PM)
UPDATES IN THE CLASSIFICATION OF NECK DISSECTION
Alfredo Q.Y. Pontejos, M.D. (Philippines)
In the 1800’s, Kocher, Billroth, von Lagenbeck, and von Volkmann described surgical
lymphadenectomy. In 1888, Jawdynski described in detail the first successful radical en bloc
resection of metastatic mass in the neck. In 1906, Dr. George W. Crile presented the concept of
radical neck dissection. And in 1953, Dr. Hayes Martin published articles on radical surgery of the
head and neck and described en bloc resections. Functional neck dissection was introduced by Dr.
Oswaldo Suarez in the 1960’s then Drs. Ettore Bocca, Cesar Gavilan, and Richard Jesse propagated
functional neck dissection from which selective neck dissection evolved.
Neck dissection is performed if there are obvious neck nodes and if there is a 20% chance of
neck node metastasis in head and neck cancers.
For us to understand the different kinds of neck dissection, we have to know the different
levels of the lymphatic system of the neck. American Head & Neck Society introduced in 2001 a
classification for neck dissection based on the levels of cervical lymph nodes removed. The
conceptual guidelines for neck dissection included radical neck dissection, modified radical neck
dissection, selective neck dissection, and extended radical neck dissection. In 2008, AHNS
published an update on neck dissection classification in which level VII was added to the lymph
node groups.
Problems arise when certain non-lymphatic tissues are included in the removal of lymph
nodes as in a neck dissection wherein levels I, II, III are removed plus the SCM and IJV. How will
you classify this based on the 2008 classification? So the Japanese Society of Clinical Oncology tried
to develop a classification system by which this could be addressed. However, it was even more
confusing.
In 2010, Ferlito et al proposed a new and simpler classification of neck dissection which will
be discussed in the presentation.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 1: Neck Dissection Ballroom A November 30, 2015 (3:00 - 4:00 PM)
THE ROLE OF ELECTIVE NECK DISSECTION IN HEAD & NECK CANCER
Ashok R. Shaha, M.D., FACS (USA)
The overall incidence of metastatic disease in N0 is approximately 20%. The most
important prognostic factor in the head and neck cancer is presence of metastatic disease which
reduces the overall survival by 50%. The patient’s who are likely to develop nodal disease are with
larger tumors, depth of infiltration, poorly differentiated and location of the tumor. The incidence
of nodal disease is approximately 25% in T1 cancer while it goes between 40-60% in T2 and T3
tongue cancer. The patterns of nodal metastasis are well defined in head and neck cancer. The
majority of the oral cavity cancer generally metastasize to levels I, II and III and supraomohyoid
neck dissection can be easily performed. The question always comes about surgery versus
radiation therapy. Radiation therapy is equally good and effective treatment in N0 neck however
the recent studies from Tata Memorial hospital and from Brazilian groups have shown that
performing a neck dissection in N0 state is much better that radiation itself. Once the nodal
disease is identified certain prognostic features need to be studied such as number of nodes,
extranodal extension, and the size of the tumor. Based on which further adjuvant treatment such
as postoperative radiation therapy needs to be considered. Certain complications of node
dissection specifically related to selective nodal dissection need to be recognized such as shoulder
weakness and rarely injury to the lower division of the facial nerve (marginal mandibular nerve).
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 1: Neck Dissection Ballroom A November 30, 2015 (3:00 - 4:00 PM)
THE ROLE OF THERAPEUTIC NECK DISSECTION IN HEAD & NECK CANCER
Dominiek Monserez, M.D. (Netherlands)
Head and neck malignancies frequently metastasize to the cervical lymph nodes, an
occurrence that has a markedly negative impact on prognosis. Treatment of the cervical neck
nodes, is mostly part of the treatment strategy, especially in advanced stages. When the primary
tumor is surgically treated, an ipsilateral or bilateral neck dissection is mostly warranted. The
extent of the therapeutic neck dissection is controversial. Even a modified radical neck dissection
is associated with important morbidity, which can be reduced by excluding some levels from the
resection. Depending on the nature and location of the primary tumor and the N-stage reducing
the extent of the neck dissection without hampering the prognosis can be considered.
Treatment of the neck after definitive radiotherapy, either alone or in combination with
chemotherapy, is even more complex. Traditionally, up to 50% of node positive patients treated
with radiotherapy alone had persistent nodal disease on pathology, which provided the rationale
for a planned neck dissection following definitive radiotherapy. As a result half of the patients
were affected by unnecessary morbidity and complications. Patients with a high risk on residual
nodal disease could benefit of an upfront neck dissection, taken in consideration that treatment of
the primary tumor is delayed. Improvement of RT techniques and the use of chemo radiotherapy
advances in post-treatment restaging and the increase of HPV-related (oropharyngeal) cancers,
decreased the risk of isolated nodal failure significantly. Nowadays observation is preferred over
surgery in the absence of evidence for residual nodal disease or an increased risk of recurrence.
When regional salvage surgery is necessary its extent should be tailored to the residual nodal
disease and the neck levels involved.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 2: NPCA Ballroom B November 30, 2015 (3:00 - 4:00 PM)
SALVAGE NASOPHARYNGECTOMY FOR rNPCA FROM OPEN TO ENDOSCOPIC
Sheng-Po Hao, M.D., FACS, FICS (Taiwan)
Nasopharyngeal carcinoma (NPC) is a common cancer among the Chinese people. NPC is a
squamous cell carcinoma which originates from the epithelial lining of the nasopharynx. Currently
available therapeutic modalities for NPC are radiation therapy (RT), chemotherapy, or a
combination of both. NPC is highly radiosensitive and patients presenting with limited stage
cancer have a high possibility for cure after RT. Concurrent cisplatin based chemo-radiotherapy
with or without neo-adjuvant chemotherapy is currently the standard treatment for patients with
advanced locoregional disease. Though NPC is usually a radiosensitive tumor, some do recur after
RT. Local failure, either persistence or recurrence, in the nasopharynx, occurs in 10% to 30% of
patients with NPC after initial RT.
Salvage nasopharyngectomy has been the mainstay of treatment after RT failure. Surgical
access to the nasopharynx has been a challenge to head and neck surgeons for years. Various
surgical approaches to the nasopharynx have been developed, such as the transpalatal,
transmaxillary, midline mandibulotomy, transpterygoid, facial translocation, and infratemporal
fossa approaches. However, in recent years, there is a paradigm shift for nasopharyngectomy, that
is from open to endoscopic. Minimally invasive endoscopic nasopharyngectomy has been reported
to be a feasible treatment of a small mucosal recurrence. The indication of endoscopic
nasopharyngectomy for rNPC includes lesions of the central roof or floor with minimal lateral
extension. With the aid of navigation, endoscopic nasopharyngectomy can also be a good surgical
intervention in rNPC cases even with skull base bone involvement.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 2: NPCA Ballroom B November 30, 2015 (3:00 - 4:00 PM)
ALL THAT IS NEW IN RADIATION TREATMENT OF NASOPHARYNGEAL
CARCINOMAS
Johanna Patricia A. Cañal, M.D., MHA (Philippines)
This short talk discusses the technology available for radiotherapy of nasopharyngeal
carcinomas and head and neck tumors today, both abroad and in the Philippines. It includes
advances in both imaging, which is the basis of treatment, and treatment delivery, the op-
erative principle being precision in both dose and target.
NPCA: UPDATES ON MANAGEMENT WITH CHEMOTHERAPY Marlinda Adham, M.D. (Indonesia)
Nasopharyngeal carcinoma (NPC) is endemic in Southern China and Southeast Asia. NPC
is a highly radiosensitive tumor that radiotherapy is the mainstay of treatment with an overall 5-
year survival rate of 40~70%. Although early-stage NPC is highly radiocurable, the treatment
results of locoregionally advanced NPC have been disappointing because of local recurrence and
distant metastases. Several prospective randomized trials and meta-analyses have demonstrated
that concurrent chemoradiotherapy (CCRT) with or without adjuvant chemotherapy is superior to
RT alone in the treatment of locoregionally advanced NPC. The benefit of concurrent
chemoradiotherapy in treating locoregionally advanced NPC is welll established with long-term
survival rates remarkably being improved to 60-70%, but this approach gave a high rate of acute
radiation therapyinduced toxicity and late systemic recurrence. Recent advances in molecular
biology have provided a detailed understanding of the molecular events in carcinogenesis and
may now offer new approaches to the treatment of NPC. Targeted therapies remain a major area of
interest and EGFR has long been hypothesized to be a strategic target in the development of novel
therapies for the treatment of cancer. This overexpression correlates with a poor clinical outcome
in a number of malignancies. Therefore, blockade of EGFR activity would interrupt EGFR-
mediated signal transduction pathways and result in suppression of tumor growth.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 3: Raman Spectroscopy & Phytotherapy Ballroom A November 30, 2015 (4:00 - 5:00 PM)
RESECTION MARGINS IN ORAL CAVITY TUMOR AND RAMAN SPECTROSCOPY
Jose Angelito U. Hardillo, M.D., PhD (Netherlands)
Most oral cancers arise from the epithelium of the mucosal surfaces and are referred to as
oral cavity squamous cell carcinoma (OCSCC). Despite advances in treatment modalities (surgery,
radiotherapy, chemotherapy), survival has not shown significant improvement over the last
decades. Surgery is the mainstay of treatment for OCSCC with adequate tumor resection margins
and preservation of function as the main goals. Adequate resection margins are crucial for disease
control and survival. Although patients with inadequate tumor resection can receive adjuvant
treatment (chemo and or radiation), such treatment can significantly add to the morbidity of
surgery. Recently we reported that adequate resection margins are achieved in only 15% of cases
owing to the complex anatomy of the oral cavity and the difficulty of relying on visual inspection
and palpation by the surgeon, to warrant an adequate resection. Even frozen section procedure, a
time consuming and labor intensive technique, does little to improve the situation as it only allows
inspection of a small portion of the resection margin which may not be representative of all the
margins.
In this symposium, we will discuss the technique of “specimen driven” intraoperative
assessment of resected tissues, our experience with this technique, its merits and limitations in oral
cavity cancer surgery. Finally, we will present Raman spectroscopy, an objective, fast, and less
costly technique which is suitable for a real-time assessment of resection margins.
PHYTOTHERAPY FOR HEAD & NECK CANCER
Prof. Lars Eric Pontus Stierna, M.D., PhD (Sweden)
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 4: Sinonasal & Orbital Tumors Ballroom B November 30, 2015 (4:00 - 5:00 PM)
MANAGEMENT OF INVERTED PAPILLOMA IN THE NEW MILLENNIUM
Dominiek Monserez, M.D. (Netherlands)
Since the first description of inverting papilloma by Ward in 1865, the tendency towards
local destruction, risk of recurrence and the potential malignant transformation into squamous cell
carcinoma has been constantly emphasized. Sinonasal inverted papilloma (IP) is a neoplasm from
a single progenitor cell originating of the Schneiderian membrane. Human papilloma virus (HPV)
is currently thought to be the leading cofactor in the pathogenesis of IP as an early event in the
multistep tumorigenesis process. The diagnosis is based on clinical suspicion, complemented with
CT and/or MRI, established by histological examination of a biopsy. Many staging systems are
developed since the endoscopic era. The Krouse staging system is most commonly used, although
not designed nor validated as a prognostic tool. Treatment strategy should aim at complete
removal at the first attempt and also effectuate a post-operative situation that allows endoscopic
surveillance. Recurrence rates are influenced by previous surgery, surgical techniques and abilities,
tumorstaging and length of (minimal) follow up. Synchronous squamous cell carcinoma is the
most predominant associated malignancy. There is no consensus on the length and frequency of
follow up. We report on our results of 247 patients treated in a single institution with a minimal
follow up of 24 months. We elaborate on the possible role of SCC-antigen tumor marker during
follow up.
CONQUERING CONUNDRUMS IN ORBITAL TUMORS AND PSEUDOTUMORS
Ma. Donna Santiago, M.D., MBA (Philippines)
This lecture characterizes the clinical and pathological features of patients with
histopathology-confirmed orbital neoplasms and pseudotumors, including neoplasms from
adjacent sinuses that extended into the orbit. The preoperative evaluation, diagnostic imaging and
management will also be discussed.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 5: Apps and EMR Ballroom A December 1, 2015 (1:30 - 2:30 PM)
MOBILE APPLICATIONS FOR THE #ConnectedENT
Philip B. Fullante, M.D. (Philippines)
The year 2015 has seen the tremendous growth of information and communication
technology in everyday use. People and information are now just a screen tap away on our phones
and tablets. Social media and blog sites have conveniently given us access to people and
information that are previously too hard to find. Medical professionals, especially
otorhinolaryngologists, can take advantage of this information explosion in the Internet to improve
health care delivery in clinical practice. We only need to know and use the right tools to become
#connectedENTs. This lecture will present some of the useful mobile apps that even the not-so-tech
-savvy otorhinolaryngologist can use in clinical practice.
ELECTRONIC MEDICAL RECORDS IN THE PHILIPPINES: CURRENT STATE,
BENEFITS AND CHALLENGES
Michael Hussin B. Muin, M.D. (Philippines)
The need for electronic medical records in physician practices is growing. The lecture will
highlight the current state of EMR options in the Philippines, the benefits of using IT-enabled
clinical documentation and the challenges moving forward.
COMPUTERIZING THE PRACTICE AND LEVERAGING THE INFORMATION
Jerry Rapes (Philippines)
Willex Prez (Philippines)
Healthcare delivery is undergoing transformation brought about by sweeping
digital tide. Fundamental to improving patient outcomes, the growing use of electronic
medical records or EMR involves not just finding the right technology but also, promoting
its adoption and use among doctors via usability and managing culture change by
challenging perceived myths and gaining better understanding of the future of healthcare
through use of IT.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 6: New Technologies Ballroom B December 1, 2015 (1:30 - 2:30 PM)
SELF-DEVELOPED ROBOT FOR COCHLEA IMPLANTATION: REALITY OR
FUTURE?
Prof. Marco D. Caversaccio, M.D. (Switzerland)
The aims of minimally invasive cochlear implant surgery are manifold. Different surgical
methods exist such the suprameatal, transcanal or pericanal approach.These methods aim to avoid
wide mastoidectomies while at the same time targeting the round window of the cochlea. In the
last 10 years, patient-specific stereotactic templates, skull-mounted or more conventional
image-guided robotic approaches have been presented by different groups. Robotic minimally
invasive access to the cochlea is gained through a direct cochlear access, which is a small tunnel
drilled from the mastoid surface to the cochlea passing through the facial recess. In addition in a
minimaly invasive access, the preservation of intracochlear structures during and after electrode
array insertion is an important research topic. Since 2008 we are developing in Bern our own robot
for hearing implants together with our Biomedical Engineering center (ARTORG). Tests on human
cadaver heads show high precision of our self-constructed robot and is approved by the Swiss
Ethical Committee for surgery.
Acknowledgments: supported by the Swiss National Science Foundation (Nano Tera
www.nano-tera.ch ), the Hear-EU project FP7 www.hear-eu.eu and Med-EL. Artorg:
www.artorg.unibe.ch Prof. S. Weber
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 6: New Technologies Ballroom B December 1, 2015 (1:30 - 2:30 PM)
POSSIBLE INDICATIONS FOR COMPUTER AIDED SURGERY ON THE LATERAL
SKULL BASE
Prof. Marco D. Caversaccio, M.D. (Switzerland)
Navigation surgery of the lateral skull base is a rare intervention in daily practice. It’s often
a delicate and difficult minimal invasive intervention in a narrow space. Therefore the orientation
in the temporal bone is often difficult. In case of aural atresia or tumors the normal anatomical
landmarks are often missing rendering the orientation more difficult. Navigation together with
imaging like CT, MR and Angiography support the surgeon in such cases to perform the operation
more accurate and in some cases also in shorter time. With the incorporation of augmented reality,
image-guided PET-CT , actual cone beam CT images surgery will evolve into « information guided
surgery ». Since 18 years we are developing and evaluating enabling navigations surgery tools for
simulation, planning, training, education and performance in Bern. This clinically applied
technological research was complemented by a series of patients.Worldwide, no clear indications
for navigated surgery on the lateral skull base exist.
Acknowledgments: supported by the Swiss National Science Foundation www.co-me.ch
and the Commission of Technology and Innovation in Switzerland. ISTB : Prof. L.P. Nolte
www.istb.unibe.ch; and ARTORG : Prof. S. Weber www.artorg.unibe.ch
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 6: New Technologies Ballroom B December 1, 2015 (1:30 - 2:30 PM)
A NEW & COMPLETE TOOL FOR ENT SURGEONS IN DIAGNOSING OSAS
Magne Tvinnereim, M.D., PhD (Norway)
New pathological implications as well as documentation of frequent comorbidities has led
to new demands regarding the Diagnosis of OSAS.
Earlier the focus was merely on episodes with increased Respiratory Effort (RE), quantified
by the Apnea-Hypopnea index (AHI).
More recently, it has become evident that episodes without changed airflow- and oxygen
saturation- patterns but with increased RE and simultaneous awakenings (Arousals), represent
pathology as well. This entity is the Respiratory Effort Related Arousals (RERA) and is included in
the terminology: OSA = RERA + AHI = RDI, where RDI (Respiratory Distress Index), represents the
total amount of pathological OSA events.
Hitherto the Arousal detection has demanded PSG with EEG recordings. A newly
innovated physiological parameter replaces these time consuming investigations.
An algorithm using the Gold standard for OSAS diagnosis, the Oesophageal Pressure, combined
with recorded, well-known physiological variables has been established.
A newly developed 0.8 mm thin, soft oesophageal catheter with advanced high-tech micro
pressure-transducers is engaged in giving the complete OSAS diagnosis as well as the Level of
Pharyngeal Obstruction. The latter is mandatory for the ENT – surgeon in the preoperative
evaluation. As RERA is a mild form of OSA, this group is also more prone to successful surgery.
The ApneaGraph Spiro encompasses the innovations and upgrades in one solution. It
comprises a complete, automated, cost-effective and user friendly tool for the ENT – Surgeon when
dealing with OSAS, regarding Diagnosis as well as Treatment Selection.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 7: Laryngeal Oncology & Vocology Ballroom A December 1, 2015 (2:30 - 3:30 PM)
LASER SURGERY FOR EARLY STAGE LARYNGEAL CANCER
William L. Lim, M.D. (Philippines)
LASER SURGERY IN MANAGEMENT OF RECURRENT LARYNGEAL CANCER
Prof. Dr. Robert J. Baatenburg De Jong (Netherlands)
VOICE CARE ESSENTIALS: PORTABLE VOICE AMPLIFIER & VOCAL AEROBICS
Mary Arlene A. Bongosia, M.D. (Philippines)
Our advocacy is to promote vocal health. Voice abuse is common among professional
voice users especially teachers. When there is more effort to be heard, there is a need to amplify
voice. A portable voice amplifier is recommended. A number of portable voice amplifiers are
available in the market, but we need to be aware of the specifications, the ratio of decibels, wattage
output to room size, number of people and other factors. With the voice amplifier, voice exercises,
called voice aerobics can augment vocal endurance and stamina.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 8: Skull Base Tumors/ OSA Ballroom B December 1, 2015 (2:30 - 3:30 PM)
HOSPITAL INFORMATION SYSTEM FOR THE FUTURE: SNUBH WAY
Chae-Seo Rhee, M.D. (South Korea)
Seoul National University Bundang Hospital (SNUBH) had opened at 2003 with
implementation of BESTCare, a fully digitalized hospital information system. SNUBH started with
4 less; chartless, filmless, slipless, and paperless. SNUBH is the first hospital outside the US to
receive the HIMSS Stage 7 accreditation with its home-grown EMR system at 2010. We launched
next generation hospital information system (HIS) BESTCare 2.0 which implemented Saudi Arabia.
The hospital’s award-winning N-Device Strategy deploys health IT in various healthcare settings.
SNUBH SMART Hospital strategy is extremely useful for the doctors, nurses, pharmacists and
administrators and is also very helpful for the patients. N-device based on VDI-system means
any-time, any-where, any-device, which consists of mobile EMR, mobile e-consent, BEST board,
information prescription, SMART bedside station and SMART patient guide and personal health
record.
With clinical data warehouse, big data can easily applicate to medical research and
healthcare outcome. Patient care is also continuously and easily monitored for safety and quality.
In this session, I will introduce the latest SNUBH SMART Hospital solutions.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 8: Skull Base Tumors/ OSA Ballroom B December 1, 2015 (2:30 - 3:30 PM)
SUBLINGUAL IMMUNOTHERAPY IN KOREA: PERSPECTIVE FROM
RHINOLOGISTS
Chae-Seo Rhee, M.D. (South Korea)
The prevalence of allergic rhinitis (AR) in the general population is increasing and
currently estimated to be approximately 10-25%. Although AR is not associated with a risk of
death, the disorder can have a considerable effect on a patient’s quality of life. Consideration of
comorbid diseases, including asthma, nasal polyp, olfactory dysfunction and chronic
rhinosinusitis, results in a tremendous increase in the medical cost for AR treatment, which has
come to entail more than just treating the rhinitis itself.
Majority of patients with AR are diagnosed by ENT specialists or general practice physician
in Asia-Pacific area. The results of the published data suggest that ENT specialists most commonly
encounter patients with AR triggered by one or multiple inhalant allergens. Thus, ENT specialists
are mainly responsible for the primary treament of AR.
Among the current treatment options for AR, specific allergen immunotherapy including
subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) is the only medical
intervention that modifies fundamental immunologic mechanisms by inducing tolerance, and it
can also modify the natural course of the disease.
SLIT has recently received much attention around the world as a primary treatment for AR
and is now widely used as a replacement for subcutaneous administration, even in Korea. The
efficacy and safety of SLIT have been established by many clinical trials, studies, and
meta-analyses, and its long-term effects and prevention of asthma progression have been
suggested.
In this session, I will talk about the SLIT with our reported experiences regarding efficacy,
safety, prevention of progression to asthma, mono-allergen treatment to poly-sensitized patients,
and cost-benefit issues.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 8: Skull Base Tumors/ OSA Ballroom B December 1, 2015 (2:30 - 3:30 PM)
INNOVATIONS IN THE DIAGNOSIS & MANAGEMENT OF OSAS
Magne Tvinnereim, M.D., PhD (Norway)
Obstructive Sleep Apnea Syndrome (OSAS) is caused by pharyngeal relaxation during
sleep, resulting in upper airway narrowing and compromised breathing. The number of apneas
and hypopneas per hour of sleep is the AHI. The Gold standard for measuring these events, the
Respiratory Effort (RE), is Oesophageal Pressure (AASM 2007). Moreover, partly compromised
breathing is found to increase the RE, and frequently lead to Arousals from sleep. Harmful
implications like those documented for the apneas/hypopneas are found. Such episodes, named
Respiratory Effort Related Arousals (RERA) are now incorporated in the OSA definition; OSA =
AHI + RERA = RDI, where RDI (Respiratory Distress Index) is the sum of AHI and RERA events
per hour of sleep. (AASM, 2007, 2013)
Incorporation of RERAs increases the number of relatively light OSA sufferers
considerably. Hitherto, use of PSG (PolySomnoGraphy) with EEG (ElectroEncephaloGraphic)
recordings has been used for detecting Arousals. This is no longer necessary.
An innovated algorithm based on measurements of Oesophageal Pressure along with
changes in physiological parameters detecting Arousals, can diagnose RERA and OSA.
A user-friendly device for reliable, fully automatized, complete and cost-effective home diagnosis
for the upgraded OSAS, the ApneaGraph® Spiro (AGS), is developed. The innovations and
practical implications for facilitating the ENT doctor’s diagnostic setup will be described.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 9: Computer Aided Surgery Ballroom A December 2, 2015 (1:30 - 2:30 PM)
IMPROVING OUTCOMES WITH PREOPERATIVE 3D PLANNING & COMPUTER
AIDED SURGERY IN CRANIOMAXILLOFACIAL RECONSTRUCTION
Francis V. Roasa, M.D. (Philippines)
Craniomaxillofacial reconstruction for trauma or oncologic surgery is traditionally planned
using 2 dimensional modalities and operated on using reconstructive techniques that heavily rely
on the surgeon’s experience with intraoperative trial and error, leading to prolonged surgical time.
The slow learning curve inherent to this type of surgery often fails to achieve consistent and
predictable outcomes and this leads to functional and cosmetic deformities that are very difficult to
correct. Preoperative planning using 3-Dimensional Technology and computer-aided surgery has
contributed significantly to improved outcome of major reconstructive craniomaxillofacial surgery
and considerable improvement in operative time. The precise planning and execution of the
reconstruction often leads to restoration of facial symmetry, appearance, and function that are
difficult to achieve by traditional techniques. The use of biocompatible and bioresorbable materials
together with computer printing technology to create scaffolds has opened possibilities for patients
not amenable to having additional surgery for donor harvesting. Future integration of these
scaffolds with the patients’ own cells/tissues and growth factors may provide possibilities wherein
donor harvesting would be a thing of the past. Preoperative 3-D planning and computer-aided
surgery are evolving techniques and will potentially become popular in clinical practice in the
search to achieve accurate, consistent and predictable outcomes in craniomaxillofacial
reconstruction.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 9: Computer Aided Surgery Ballroom A December 2, 2015 (1:30 - 2:30 PM)
IMPROVING OUTCOMES WITH COMPUTER PLANNING AND INTRA
OPERATIVE NAVIGATION IN CRANIOMAXILLOFACIAL SURGERY
Ferdinand G. Pamintuan, M.D. (Philippines)
Preoperative computer design and stereolithographic modeling combined with
intraoperative navigation provide a useful guide for and more accurate reconstruction of a variety
of complex cranio-maxillofacial deformities. Although probably not necessary for routine use,
computer-assisted surgery is indicated for complex posttraumatic or postablative reconstruction of
the orbits, cranium, maxilla, and mandible; temporomandibular, orthognathic surgery. Computer-
assisted preoperative planning and surgery thus advance the difficult surgical field of
craniomaxillofacial cases, particularly through a greater exploitation of radiologic information
without additional radiation to the patient
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 10: Pediatric ORL: JNA and Vasculars Tumors Ballroom B December 2, 2015 (1:30 - 2:30 PM)
SURGICAL MANAGEMENT FOR JUVENILE NASOPHARYNGEAL
ANGIOFIBROMA
Lyra V. Veloro, M.D. (Philippines)
Juvenile nasopharyngeal angiofibroma (JNA) is a rare, highly-vascularized benign disease
that is mainly diagnosed in adolescent males. It classically presents with nasal obstruction,
epistaxis and a nasopharyngeal mass. It is considered to originate from the area of the
sphenopalatine foramen and its blood supply is usually from the internal maxillary artery. JNA is
locally invasive and destructive, often involving the nasal cavity, paranasal sinuses, orbit,
pterygomaxillary and infratemporal fossae, cavernous sinus, and cranial fossa.
Contrast-enhanced CT and MR scans as well as an angiogram can help determine diagnosis and
extent of the lesion. Various staging criteria were developed for evaluating JNA although none is
universally accepted. Surgery is considered the treatment of choice in the majority of patients
with JNA. Surgical techniques include open surgical approach, endoscopic surgery, or combined
approaches depending on the stage of the tumor. The current recommendation is to carry out
tumoral embolization prior to proceeding with any of the known surgical techniques.
Understanding the advantages and limitations of these techniques is critical in the surgical
management of patients with JNA.
TREATMENT OPTIONS FOR PEDIATRIC VASCULAR TUMORS OF THE HEAD
AND NECK
Cecilia Gretchen S. Navarro-Locsin, M.D. (Philippines)
Head and neck involvement of vascular tumors ranges from 70%-80%. Over the years
treatment of these lesions has evolved as a result of a greater understanding of the molecular
biology and pathophysiology of the disease plus advances in medical targeted therapy and
surgical techniques. The treatment options available for these tumors will be reviewed. Finally, the
institutional experience on management of these tumors will be discussed and some current
research previewed.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 11: Sleep Ballroom A December 2, 2015 (2:30 - 3:30 PM)
WEARABLE FOR SLEEP
Keith Romeo A. Aguilera, M.D. (Philippines)
EFFECT OF HEAD & NECK CANCER ON SLEEP
Jonalyn Chris T. Ang, M.D. (Philippines)
Patients with cancer complain of sleep disturbances which contribute to decrease quality of
life. In a large questionnaire study of over 900 patients with different types of cancer, fatigue (44%),
insomnia (31%) and excessive sleepiness (28%) were the most prevalent complaints. Sleep
disordered breathing appears to be more frequent in patients with head and neck cancer. It can be
due to the cancer or the effect of cancer treatment.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 12: Current Concepts: COM & Skull Base Surgery Ballroom B December 2, 2015 (2:30 - 3:30 PM)
NHSRC REGISTRY: AN IT MODEL
Ryan Julius Bañez, M.D. (Philippines)
TELEMETRY UNLEASHED: A SINGAPOREAN EXPERIENCE WITH REMOTE
ASSISTANTS IN INTRAOPERATIVE NEURAL RESPONSE TELEMETRY
Barrie Yau Boon Tan, M.D. (Singapore)
Neural Response Telemetry or its equivalent has been an important and useful
intra-operative adjunct to a safe and smooth cochlear implantation during implant surgery. This
technology is usually applied in the form of a software program installed in a laptop. This then
communicates via a wire to a speech processor that can be applied directly onto the operation field
magnetically to perform the telemetry. With the advent of wireless technology, there is now the
option of communicating with the speech processor during NRT wirelessly. In this presentation,
we share our early experiences with one such advance. The CR120 Intraoperative Remote Assistant
is now the preferred mode of performing the NRT for all implants from the Cochlear Ltd company.
The feedback from surgeons and audiologists will be compiled and presented.
COCHLEAR IMPLANTS IN SINGLE SIDED DEAFNESS FOR SUDDEN
SENSORINEURAL HEARING LOSS: EARLY FINDINGS OF A SINGAPOREAN
PROSPECTIVE STUDY
Barrie Yau Boon Tan, M.D. (Singapore)
The traditional surgical indication for cochlear implantation is in bilateral profound
sensorineural hearing loss. In recent years, there has been evidence to suggest that cochlear
implantation for single sided deafness has significant benefits in terms of sound localisation and
tinnitus control. A prospective study was performed to study the benefits of cochlear implantation
in single sided deafness due to idiopathic sudden sensorineural hearing loss of recent duration less
than 5 years. The early findings of this study is presented in the form of case series discussion and
correlation made with the current published medical literature on this subject.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 13: Plastic Surgery in ORL Ballroom A December 2, 2015 (3:30 - 4:30 PM)
CUTANEOUS SURGERY
John M. Hodges, M.D., FACS (USA)
Soft tissue surgery is an integral part of ENT. In this presentation, excision, suture
technique, linear closing, and flaps will be addressed as well as scar revision procedures and
dermabrasion . Malignant lesions of the head and neck and Mohs micrographic surgery will also
be discussed.
CREATING A FUNCTIONAL NOSE WITH RHINOPLASTY
John M. Hodges, M.D., FACS (USA)
An essential element of functional reconstructive nasal surgery is septoplasty. In addition
to this surgical technique, assessment of the profile, nasal tip, and middle vault and their
respective corrective procedures will be discussed.
FACIAL PLASTIC SURGERY OVERVIEW
John M. Hodges, M.D., FACS (USA)
In facial cosmetic procedures, there are several factors a physician must take into
consideration when planning surgery. Patient classification, knowledge of anatomy, and various
surgical techniques will assist the surgeon in planning for an optimal result. Danger zones, risk
factors, surgical approaches, and post-operative complications of facelift, blepharoplasty, and
forehead lift will be discussed.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (SYMPOSIUM)
SYMPOSIUM 14: Audiology Ballroom B December 2, 2015 (2:30 - 3:30 PM)
STIMULUS CONSIDERATIONS FOR ABR & ASSR RECORDING
Andre Lodwig, M.D. (Germany)
Applying a simple delay line cochlear model can explain many known effects of stimulus
selection and parameterization on ABR and ASSR recording. For example, a broadband chirp
evokes stronger ABR responses than a click of the same Hearing Level and higher frequency ASSR
stimuli tend to produce higher responses than lower frequency stimuli. Most of these observations
can be accounted to cochlear mechanics of which examples will be given
IMPACT OF STIMULUS SELECTION ON ABR / ASSR PERFORMANCE
Russell Higgs (United Kingdom)
With examples of live patient recordings the known effects of stimulus selection and
parameterization on ABR and ASSR recordings will be demonstrated.
For example, a broadband chirp evokes stronger ABR responses than a click of the same
Hearing Level and higher frequency ASSR stimuli tend to produce higher responses than lower
frequency stimuli. It is with a greater understanding of these factors that optimized test sequences
can be employed leading to improved results and faster test times.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
ABSTRACTS (LUNCH SYMPOSIUM)
LUNCH SYMPOSIUM 2: Ballrooms A & B December 2, 2015 (11:30 AM - 1:00 PM)
SIMPLIFYING LPR DIAGNOSIS & ASSESSMENT OF THERAPY:
THE FILIPINO REFLUX SYMPTOM INDEX
Jose Florencio F. Lapeña Jr., M.D. (Philippines)
Laryngopharyngeal Reflux (LPR) disease affects up to 10% of patients consulting an
otolaryngologist, and is more common in Asians than previously recognized. In addition to diet
and lifestyle modification, LPR is presumptively treated by Proton Pump Inhibitors (PPIs).
Laryngopharyngeal Reflux (LPR) disease can be diagnosed by the Reflux Symptom Index (RSI), as
well as the Reflux Finding Score (RFS) (Belafsky et al., 2002; 2001). Because it is found in more than
50% of patients with hoarseness, it might also be indirectly (albeit partly) diagnosed by the Voice
Handicap Index (VHI) (Jacobson et al., 1997).
Responding to a need for standardized, validated culture-specific versions of these
measures and both the RSI and VHI have been translated into Filipino – the Filipino Reflux
Symptom Index (FRSI) (Lapeña, 2012) and the Filipino Voice Handicap Index (FVHI) (Umali &
Hernandez, 2006)], but the former has not been validated. Establishing the consistency, validity
and reliability of the Filipino Reflux Symptom Index (FRSI) may provide a simple, inexpensive tool
for diagnosis and clinical assessment of therapy that can be used among over 100 million Filipinos
worldwide, particularly in primary health care settings.
This session discusses the results and recommendations of a study aimed to establish the
internal consistency, validity and reliability of the Filipino Reflux Symptom Index (FRSI) among a
sample of Filipino patients and controls, and to test the validated FRSI among a sample of Filipino
patients with Laryngopharyngeal Reflux (LPR) disease before, and after a six-month trial of
Rabeprazole.
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
FOREIGN SPEAKERS’ DIRECTORY
Ashok R. Shaha, M.D., FACS (USA)
Attending Surgeon
Memorial Sloan Kettering Cancer Center
1275 York Ave, New York NY 10065
Phone: 212-639-7649
Email: [email protected]
Marlinda Adham, M.D. (Indonesia)
Staff in Oncology Subdivision
ENT Department, Faculty of Medicine,
University of Indonesia, Jakarta
Phone: +62811812363/ +6281291674763
Email: [email protected]
Prof. Marco Caversaccio, M.D.
(Switzerland)
Chairman, Department of ENT - Head &
Neck Surgery
University of Bern, Switzerland
Phone: +41 31 632 29 21
Email: [email protected]
Dominiek Andre Monserez, M.D.
(Netherlands)
Academic Medical Specialist
Erasmus University Medical Center
Rotterdam, Netherlands
Email: [email protected]
Jose Angelito U. Hardillo, M.D., PhD
(Netherlands)
Academic Medical Specialist 8
Erasmus University Medical Center,
Rotterdam, Netherlands
Phone: +31-10-7032688
Email: [email protected]
Prof. Lars Eric Pontus Stierna, M.D., PhD
(Sweden)
Professor and Lecturer
Karolinska Institute and University Hospital
Stockholm, Sweden
Email: [email protected]
Sheng - Po Hao, M.D., FACS, FICS
(Taiwan)
Professor & Chairman
Shin Kong Wu Ho-Su Memorial Hospi-
tal School of Medicine
Fu Jen Catholic University
Taipei, Taiwan
Phone: +886-2-28332211 Ext. 2556
Email: [email protected]
Magne Tvinnereim, M.D., PhD (Norway)
CEO
Spiro Medical AS
Bergen, Norway
Phone: +47 9001 6530
Email: [email protected]
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
FOREIGN SPEAKERS’ DIRECTORY
Prof. Dr. Robert Baatenburg De Jong
(Netherlands)
Professor and Chairman
Department of Otorhinolaryngology -
Head and Neck Surgery
Erasmus Medical Center, Netherlands
Email:
Barrie Yau Boon Tan, M.D. (Singapore)
Director, Center for Hearing & Ear Implants
Singapore General Hospital
Email: [email protected]
Chae-Seo Rhee, M.D. (South Korea)
Professor
Seoul National University Bundang
Hospital
Seoul, South Korea
Phone: +82-10-3892-6618
Email: [email protected]
Andre Lodwig, M.D. (Germany)
R & D Director
PATH Medical GmbH
Germering, Germany
Phone: +49 89 80076502/ +49 176 61241779
Email: [email protected]
John M. Hodges, M.D., FACS (USA)
Professor
Department of Otolaryngology - Head
and Neck Surgery
University of Tennessee Health Science
Center
Memphis, TN 38163
Phone: 901.233.4374
Email: [email protected]
Russell Higgs (United Kingdom)
International Sales Manager
PATH Medical GmbH
Germering, Germany
Phone: +44 (0) 7720 545950 / +44 (0) 1438 940775
Email: [email protected]
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
LOCAL SPEAKERS’ DIRECTORY
Alfredo Q.Y. Pontejos Jr., M.D.
Chairman, Dept. of ORL - HNS
UP College of Medicine - Philippine General
Hospital
Tel. No: (02) 526 4360, 554 8467
Email: [email protected]
Philip B. Fullante, M.D.
Clinical Associate Professor
UP College of Medicine - Philippine General
Hospital
Tel. No.: (0922) 851 0986
Johanna Patricia A. Cañal, M.D., MHA
Professor 4
UP College of Medicine - Philippine General
Hospital
Tel. No.: (02) 554 8471
Email: [email protected]
Michael Hussin B. Muin, M.D.
Healthcare IT Consultant
MedProjects, Inc.
Tel. No.: (0928) 554 3435
Email: [email protected]
Ma. Donna Santiago, M.D., MBA
Orbit & Oculoplasty Consultant
FEU - NRMF Medical Center
St. Luke’s Medical Center
Tel. No.: (0922) 899 6352
Email: [email protected]
Jerry Rapes
Managing Director
Amihan Global Strategies Philippines
The Orient Square, F. Ortigas Jr. Road
Tel. No.: (0917) 328 8816
Email: [email protected]
Iris Thiele Isip Tan, M.D., MSc
Professor 3
Medical Informatics Unit
Department of Medicine
UP College of Medicine
Email: [email protected]
Willex Perez
CEO / President
Medcurial Inc.
5F The Orient Square, F. Ortigas Jr. Road
Email: [email protected]
Ivy D. Patdu-Calaquian, M.D., JD
Member & Legal Consultant
Dept. of Health Privacy Experts Group
Email: [email protected]
William L. Lim, M.D.
Asst. Head, Voice, Swallowing & Sinus Center
St. Luke’s Medical Center
Email: [email protected]
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
LOCAL SPEAKERS’ DIRECTORY
Mary Arlene A. Bongosia, M.D.
Consultant
St. Luke’s Medical Center
E. Rodriguez Ave., Quezon City
Tel. No.: (02) 723-0301 loc. 5090
Email: [email protected]
Cecilia Gretchen Navarro-Locsin, M.D.
Vice Chairman, Dept. of ORL-HNS
St. Luke’s Medical Center
Tel. No.: (02) 723 0108
Email: [email protected]
Jose Florencio F. Lapeña, M.D., MA
Professor 9 of Otorhinolaryngology
University Scientist III
UP College of Medicine - Philippine General
Hospital
Tel. No.: (02) 524 4455, 554 8467
Email: [email protected]
Keith Romeo A. Aguilera, M.D.
Chair, Philippine Academy of Sleep Surgery
St. Luke’s Medical Center
Email: [email protected]
Francis V. Roasa, M.D.
Chairman, Dept. of ORL - HNS
University of Santo Tomas Hospital
Tel. No.: (02) 391 6406
Email: [email protected]
Jonalyn Chris T. Ang, M.D.
Active Pediatric Consultant
Dept. of Pediatrics
Cardinal Santos Medical Center
Tel. No.: (02) 661 3669, (0920) 928 0994
Email: [email protected]
Ferdinand G. Pamintuan, M.D.
Chief of Section, Facial Plastic & Reconstruc-
tive & Maxillofacial Trauma
Dept. of ORL-HNS
University of Santo Tomas Hospital
Email: [email protected]
Ryan Julius Bañez, M.D.
Chief Medical Informatics Officer
Ateneo Graduate School of Businness
Healthcare Information & Management Society
Lyra V. Veloro, M.D.
Section Head, Pediatric Otolaryngology
The Medical City
Tel. No.: (02) 635 6789 local 5259
Email: [email protected]
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
EXHIBITORS’ DIRECTORY
A. MENARINI PHILIPPINES, INC.
4th Floor W Office Building 11th Avenue corner 28th St.
Bonifacio High Street, Bonifacio Global City, Taguig
Phone: (+63 2) 333-3895
Mobile No.: 0915-1143535
E-mail: [email protected]
Ms. Rodalie Grace ‘Bannie’ P. Baluyut
Senior Brand Manager
ABBOTT LABORATORIES
8/F Venice Corporate Center, No. 8 Turin St.
McKinley Town Center, Fort Bonifacio, Taguig City
Phone: (63-2) 822-2688
Fax: (63-2) 894-1071
E-mail: [email protected]
Ms. Rosette G. Espiritu
CME Associate Officer
ADP PHARMA CORPORATION
23/F The Taipan Place, F.Ortigas Jr. Road
Ortigas Center, Pasig City
Phone: (63-2) 988-2538
Mobile No.: 0920 9882709
E-mail: [email protected]
Ms. Jenelyn DJ. Eugenio
CME Management Associate
ALL-BIO PHARMA INC.
Unit 1418 & 1419 Cityland Herrera Tower 98
V.A. cor. Rufino St., Salcedo Village, Makati City
Phone: (63-2) 403-3568
Mobile No.: 0926-1064192
E-mail: [email protected]/[email protected]
Ms. Catherine R. Borja
Regulatory Pharmacist
ALLMED INSTRUMENTS MEDICAL SYSTEM (AIMS)
Unit 2A Aiza Building 134 Mindanao Avenue
Brgy. Bahay Toro, Quezon City
Telefax: (63-2) 930-8708
Mobile No.: 0922-8975304
E-mail: [email protected]
Ms. Rosellyn Mariano
Sales Manager
AMERICAN TECHNOLOGIES INC.
5 Ideal St. Addition Hills Mandaluyong City
Phone: (63-2) 584-0000
Fax: (63-2) 584-6868
E-mail: [email protected]
Ms. Alma Postrano
Head, Marketing Department
ARCATECH ELECTRONICS / MURACAM
Phone: (63-2) 343-1299
E-mail: [email protected]
Mobile No.: 0922-8662722
Mr. Ric Villaruz
BAYER CONSUMER CARE
36th Floor, PBCom Tower, Ayala Avenue, Makati City 1209
Phone: (63-2) 448-3895
Mobile No.: 0917-6517984
E-mail: [email protected]
Mr. Mark Canlas
CME Coordinator
BEAUMED INC.
106 Unit 204 FRDC Bldg., E Rodriguez Jr. Avenue
Ugong, Pasig City
Phone: (63-2) 470-1261
Mobile No.: 0915-9389530
E-mail: [email protected]
Ms. Jackie Reniedo
Manager
BEROVAN MARKETING INCORPORATED
1526 Rizal Avenue, Sta. Cruz, Manila
Telefax: (63-2) 711-2711
Mobile No.: 0917-3116296
E-mail: [email protected]; [email protected]
Ms. Raquel A. Roa
Business Officer
BIOMEDIS INC.
6/F Dynavision Building, 108 Rada St.
Legaspi Village, Makati City 1229
Fax: (63-2) 812-1252
Mobile No.: 0917-8209035
E-mail: [email protected]
Mr. Jeremy Ross A. Lim
CMG Specialist
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
EXHIBITORS’ DIRECTORY
CELSUS PHARMACEUTICALS PHILS. INC.
115 Scout Rallos corner 11th Jamboree Streets
Sacred Heart, Quezon City 1103
Phone: (63-2) 928-8208
Fax: (63-2) 928-0815
Mobile: 0920-9026548
E-mail: [email protected]
Mr. Andres G. Fernandez
National Sales Manager
COVIDIEN PHILS. INC. (A MEDTRONIC COMPANY)
Unit 1905-1906 Hanston Square Building
San Miguel Ave., Ortigas Center, Pasig City
Phone: (63-2) 633-8898; 500-3155
Mobile: 0917-8081180
E-mail: [email protected]
Ms. Rowena Orque
Product Specialist
DENTSTALL TRADING
2111 Legarda St., Quiapo, Manila
Phone: (63-2) 488-3218
Mobile No.: 0916-6677127
Email: [email protected]
Ms. Sherly Cabigting
Owner
DR-KIM (THE BEST HEADLIGHT AND LOUPE IN
THE WORLD)
#213 Ace Gwangmyeong Tower, 108 Haan-ro
Gwangmyeong-si, Gyeoggi-do 423-798 Korea
Phone: +82-2-2611475
Fax: +82-2-26114758
E-mail: [email protected]; Website: www.dr-kim.net
Chris Kim
Manager
DUBBEL MEDICAL CORPORATION
Unit 202 Ablaza Bldg., 117 E. Rodriguez, Sr. Ave.
Quezon City
Fax: (63-2) 740-0713
Mobile: 0922-8696065
E-mail: [email protected]
Ms. Annabelle A. Jorda
CEO / Chief Finance Manager
EAR DIAGNOSTICS INC.
G/F Cosmopolitan Church corner Apacible
Taft Avenue, Manila
Phone: (63-2) 536-7772; (033) 337-1069
Fax: (63-2) 567-1105
E-mail: [email protected]
Dr. Rodolfo B. Dela Cruz
President
FERNANDO MEDICAL ENTERPRISES, INC.
MHI Bldg., No. 2-A New York Street
Brgy. Immaculate Conception, Cubao, Quezon City
Phone: (63-2) 727-1521; 727-1532
Mobile No.: 0917-5636797; 0923-5206605
E-mail: [email protected]
Mr. Sonny D. Feliciano
Sales Manager
FIRST ASSOCIATED MEDICAL DISTRIBUTION CO.,
INC. (FAMED)
FCI Corporate Center, 1814 Philip Street
Multinational Village, Brgy. Moonwalk, Parañaque City
Phone: (63-2) 826-8523
Fax: (63-2) 788-0080
Mobile No.: 0917-8631225
E-mail: [email protected]
Ms. Jacque M. Eusebio
Sales Manager
GADGETS IN STYLE TRADING CORP.
Unit 625 Shangri-La Plaza, Edsa corner Shaw Blvd.
Mandaluyong City
Phone: (63-2) 352-5500; 959-8854
Mobile No.: 0917-5793355
E-mail: [email protected]
Mr. William Ordonia
Corporate Sales Supervisor
GETZ PHARMA
2F The Rockwell Business Ctr. Tower 1
Ortigas Avenue, Pasig City
Mobile No.: 0917-8420137
E-mail: [email protected]
Mr. Jorge Rafael P. Diño
Marketing Specialist
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
EXHIBITORS’ DIRECTORY
GLAXOSMITHKLINE PHILIPPINES, INC.
2266 Chino Roces Avenue, Makati City
Phone: (63-2) 892-0761
Mobile No.: 0917-8897027
E-mail: [email protected]
Mr. Charles Arevalo
CME Officer – Allergy & Derma
GREAT RECONSTRUCTION SURGICALS, INC.
Rm. 501-C Culmat Bldg., 1270-1330
E. Rodriguez Sr. Avenue, Quezon City
Telefax: (63-2) 725-0867
Mobile No.: 0917-5411234
E-mail: [email protected]
Ms. Zeth San Antonio
Corporate Secretary
HEALTHWORLD INTERNATIONAL PHILIPPINES
CORPORATION
421 Quirino Ave., La Huerta, Parañaque City
Phone: (63-2) 829-0175
Fax: (63-2) 826-6770
Mobile No.: 0922-8496753
E-mail: [email protected]
Ms. Mengie Cabanlit
Sales Manager
HI-EISAI PHARMACEUTICAL INC.
20th Floor Multinational Bancorporation Centre
6805 Ayala Avenue, Makati City
Phone: (63-2) 887-1075
Fax: (63-2) 887-5172
Mobile No.: 0918-9901662
E-mail: [email protected]
Ms. Macky Quidato / Ms. Cherry V. Balasbas
Senior Product Manager / Marketing Assistant
HOMECARE MEDICAL
1850 Felix Huertas St., Sta. Cruz, Manila
Phone: (63-2) 313-5450; 313-8650; 998-1615
Mobile No.: 0917 6694271; 0943-7075718
E-mail: [email protected]
Mr. Roy H. Almario
Operations Manager
HYPHENS PHARMA PHILIPPINES, INC.
Unit 3, 2nd Floor GFO Building
#122 Kamuning Road, Quezon City
Phone: (63-2) 927-7505
Fax: (63-2) 927-7506
Mobile: 0917-5583286
E-mail: [email protected]
Ms. Josiephine Sac-Mantoya
Marketing Manager
INNOGEN PHARMACEUTICALS, INC.
2nd/F MNB Bldg., 124-126 Scout Dr. Lazcano St.
Brgy. Sacred Heart, Quezon City
Phone: (63-2) 410-4613
Fax: (63-2) 374-1842
Mobile: 0932-9116865
E-mail: [email protected]
Ms. Jacin Reyes
Associate Product Manager
INOVA PHARMACEUTICALS
Unit 2802 Penthouse One Global Place 25th Street
cor. 5th Ave., BGC Taguig City, 1634
Phone: (63-2) 737-5100
Mobile No.: 0917-3285875
Email: [email protected];
Ms. Novelle de Leon-Lopez
Senior Product Manager
INTERMED MARKETING PHILIPPINES, INC.
The Paragon Corporate Centre Industry St.
Madrigal Business Park, Ayala Alabang
Muntinlupa City
Phone: (63-2) 659-0451 to 55
Fax: (63-2) 659-0472
E-mail: [email protected]
Ms. Liezl L. Abaya
Advertising & Marketing Director IOS MARKETING CORPORATION
647 P. Paterno St., Quiapo, Manila
Phone: (63-2) 733-5445
Fax: (63-2) 733-3767
Mobile No.: 0917-8347912
E-mail: [email protected]
Ms. Lenlie Villanueva
Sales Head
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
EXHIBITORS’ DIRECTORY
JOHNSON & JOHNSON PHILIPPINES
Edison Road, Barrio Ibayo, Parañaque City
Phone: (63-2) 824-8845
Mobile No.: 0917-8730395
E-mail: [email protected]
Ms. Hazel Sering
JULLSURG
WZ-118 Naraina Village, New Delhi-110028, India
Telephone: +91-11-42430347
Mobile: +91-9990659999
E-mail: [email protected]
Shivam Mahajan
Director
JUSTRIGHT PHARMACEUTICALS
#20 Palanza corner Guirayan Streets
Brgy. Doña Imelda, Quezon City
Phone: (63-2) 413-2367 loc. 108
Fax: (63-2) 412-0533
Mobile No.: 0919-9115391
E-mail: [email protected]
Mr. John Rex V. Hermoso
Product Manager
LEFORT MEDICAL TRADING CORP.
46 Banahaw St., Cubao, Quezon City
Phone: (63-2) 413-4506
Fax: (63-2) 570-9027
Mobile No.: 0920-9184159
E-mail: [email protected]
Ms. Lorie Gabiane
Sales Manager
MANILA HEARING AID CENTER
Unit 809, 8th/F Tower A, BSA Twin Tower
Ortigas Center, Mandaluyong City
Telefax: (63-2) 696-1580 loc. 108
Mobile No.: 0906-5898504
E-mail: [email protected]
Mr. John Paulo G. Dela Cruz
Marketing Associate
MEDTRONIC PHILIPPINES, INC.
Unit 810, 8th/F Sun Life Centre, 5th Avenue
Cor. Rizal Drive, Bonifacio Global City, Taguig City
Phone: (63-2) 403-5519 loc. 303
Mobile No.: 0917-7149585; 0922-8171974
E-mail: [email protected]
Mr. Marcel C. Ingalla
Market Development Specialist
MICROLAB
1157 Rodriguez Avenue, cor. Heneral Lacuña St.
Bangkal, Makati City
Phone: (63-2) 551-3839
Fax: (63-2) 831-9621
Mobile: 0917-8172825
Email: [email protected]
Mr. Navarre M. Espinoza
Sales Representative
NATRAPHARM
The Patriot Bldg. Km. 18 West Service Road
SLEX, Sucat, Parañaque City
Phone: (63-2) 821-7382
Mobile No.: 0917-8747527
E-mail: [email protected]
Mr. Ferdinand Carmelo F. Samson
Associate Product Manager
NEW MARKETLINK PHARMACEUTICAL CORP.
(ORAHEX)
2nd Floor The Corporate Centre
2291 Don Chino Roces Ave. Ext., Makati City
Phone: (63-2) 836-5838 to 47
Fax: (63-2) 976-9044
Mobile: 0917-8797605 / 0917-8544061
E-mail: [email protected]
Mr. Eugenio Santos / Mr. Gilbert Espiritu
Sales and Marketing Managers
OLTEN INSTRUMENTS PHILS. CORP.
No.16 Sampaguita St., Tomasa Subd., Ususan, Taguig City
Phone: (63-2) 628-3293
Fax: (63-2) 641-9150
Mobile No.: 0917-5514990
E-mail: [email protected]
Ms. Ruth L. Tee
Sales Manager
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
EXHIBITORS’ DIRECTORY
ONE PHARMA COMPANY, INC.
Abel Nosce St., BF Resort Village, Las Piñas City
Phone: (63-2) 871- 2941
Email: [email protected]
Ms. Jane Natividad
Marketing Administrator
PFIZER, INC.
23F Ayala Life FGU Center, 6811
Ayala Avenue, Makati City
Phone :( 63-2) 451-9200
Mobile No.: 0917-5205091
E-mail: [email protected]
Website: www.pfizer.com.ph
Mr. Carlo Jose Garcia
Country Portfolio Manager
PHAREX HEALTH CORP
Units 101-102, G/F Bldg. Alpha UP-Ayala Land TechnoHub
Commonwealth Ave., Diliman, Quezon City
Fax: (63-2) 433-8088
Mobile No.: 0998-9614001
E-mail: [email protected]
Mr. Erik Viray
Corporate Relations Manager - Events
PINES MEDICAL TRADING
14 A Sunflower St, San Luis Village, Baguio City
Phone: (074) 442-2293
Mobile No.: 0917-6870081
E-mail: [email protected]
Ms. Jonah W. Deyto
Proprietress
RECKITT BENCKISER (RB) HEALTHCARE
PHILIPPINES INC.
Unit 2202 One Global Place, 5th Ave. cor. 25th St.
Bonifacio Global City, Taguig 1634
Phone: (63-2) 889-5823 loc. 705
Fax: (63-2) 889-6293
Mobile No.: 0917-3284535
E-mail: [email protected]
Ms. Evangeline “Vangee” F. Reyes
Medical Marketing Manager, Phils.
RESWERKES PHILS., INC.
Unit 1001 The Orient Square Building
F. Ortigas, Jr. Rd., Ortigas Center, Pasig City
Phone: (63-2) 470-2931
Fax: (63-2) 470-2809
Mobile No.: 0927-3044038
E-mail: [email protected]
Ms. Kathy Dalimocon
Sales Specialist
SANDOZ PHILIPPINES CORP.
7th Floor ARCC Bldg., Gamboa and Salcedo Sts.
Legaspi Village, Makati City
Phone: (63-2) 368-7888
Fax: (63-2) 815-0101
Mobile No.: 0917-8487808
E-mail: [email protected]
Ms. Rhoda Delos Reyes
Product Manager
SAVIOUR MEDEVICES INC.
2nd Flr. Global Ent. Bldg., 138 HV Dela Costa St.
Salcedo Village, Makati City
Phone: (63-2) 812-7768
Fax: (63-2) 845-2516
Mobile No.: 0922-9091158
E-mail: [email protected]
Ms. Cristina L. Adan
Executive Vice President
SENSOMED PHILIPPINES, INC.
Unit 1508 Orient Square Bldg., F. Ortigas Jr. Road
Ortigas Center, Pasig City
Phone: (63-2) 635-5169
Fax: (63-2) 635-5170
Mobile No.: 0917-2713339
E-mail: [email protected]
Dr. Natividad N. Arriola
President & CEO
SONUS MANILA HEARING CARE CENTER
Unit 2205, 22nd Floor Jollibee Plaza Condominium Corp.
Emerald Avenue, Ortigas Center, Pasig City
Phone: (63-2) 654-2843 / 654-5935
Mobile No.: 0932-8808012 / 0932-8808054
E-mail: [email protected] /[email protected]
Mr. Carlo Turda / Mr. Ronie Eustaquio
Owners & Managing Directors
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
EXHIBITORS’ DIRECTORY
TAKEDA HEALTHCARE (PHILIPPINES) INC.
17th Floor, Zuellig Bldg. corner Paseo de Roxas
Makati Avenue, Makati City
Phone: (63-2) 575-0064
Fax: (63-2) 575-0080
E-mail: [email protected]
Ms. Camille Reyes
Associate Professional Healthcare Services Manager
THE CATHAY DRUG COMPANY INC.
2/F Vernida 1 Bldg., 120 Amorsolo St.
Legaspi Village, Makati City
Phone: (63-2) 892-5936
Fax: (63-2) 818-6739
Mobile No.: 0917-8812978
Email: [email protected]
Ms. Maria Agnes Ramos
CME Coordinator
TOPBOOKS HEALTH INFORMATION PROVIDER
INC.
Unit 6015 Golden Rock Bldg., 168 Salcedo St.
Legaspi Village, Makati City
Telefax: (63-2) 843-0082
Mobile No.: 0920-9693572
E-mail: [email protected]
Mr. Tim Lum
Manager
UNITED AMERICAN PHARMACEUTICALS, INC.
132 Pioneer Street LVP Compound, Mandaluyong City
Phone: (63-2) 858-1000
Fax: (63-2) 635-3581
Email: [email protected]; acesguer-
Mr. Rinaldo C. Enriquez
Mr. Alvin Cruz-Esguerra
UAP-Product Management Group
UNITED LABORATORIES, INC.
#66 United St., Mandaluyong City
Phone: (63-2) 858-1000 local 1970
E-mail: [email protected]
Website: www.unilab.com.ph
Mr. Rainier S. Herradura
Professional Relations Management Division
URGO-VIVA SANTE PHILIPPINES
Metro Drug Office, Taguig City
Mobile No.: 0917-5239440
E-mail: [email protected]
Website: www.vivasante.com
Mr. David P. Perianes III
Product Manager
VARIANCE TRADING CORPORATION
57-A Maliksi St., Brgy. Pinyahan, Quezon City
Fax: (63-2) 990-0600
Mobile No.: 0925-3653873
E-mail: [email protected]
Ms. Reina Valerie C. Maglinte
Business Development Manager
VOLVO NORTH EDSA
Phone: (63-2) 376-4965
Mobile No.: 0917-8118165
Mr. Doy Montemayor
Branch Manager
WESTMONT PHARMACEUTICALS
4th Floor, Bonaventure Plaza, Ortigas Avenue
Greenhills, San Juan City
Phone: (63-2) 858-1277
Mobile: 0917-8209625
E-mail: [email protected]
Ms. Jennifer Lim
CME Officer
ZYDUS HEALTHCARE PHILS., INC.
9/F Eco Tower, 9th Avenue cor. 32nd Streets
Bonifacio Global City, Taguig
Mobile No.: 0917-8250550
E-mail: [email protected]
Ms. Caroline T. Lim
BDM
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
SPONSORS & EXHIBITORS BOOTH LAYOUT
COMPANY NAME FOYER
UNILAB / UAP F1
A. MENARINI PHILIPPINES, INC. F2
BIOMEDIS F3
HI-EISAI F4
SANDOZ PHILIPPINES CORP. F5
NATRAPHARM, INC. F6
DR-KIM F7
ABBOTT PRODUCTS PHILS., INC. F8
COMPANY NAME BOOTH NO.
JOHNSON & JOHNSON PHILS., INC. B1
INOVA PHARMACEUTICALS B2
VOLVO NORTH EDSA B3
GLAXOSMITHLINE PHILS., INC. B4
ADP PHARMA CORP. B5
THE CATHAY DRUG CO., INC. B6
JUSTRIGHT PHARMACEUTICALS B7
NEW MARKETLINK PHARMA CORP. (ORAHEX) B8 & B9
ZYDUS HEALTHCARE PHILS., INC. B10
BEAUMED, INC. B11
DUBBEL MEDICAL CORPORATION B12 & B13
TOPBOOKS B14
GLAMOURBOX BOUTIQUE B15
CITIBANK B16
PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress
SPONSORS’/ EXHIBITORS’ BOOTH LAYOUT
COMPANY NAME BOOTH NO.
MANULIFE B17
GADGETS IN STYLE TRADING CORP. B18 & B19
HEALTHWORLD B20
HOMECARE MEDICAL B21
ARCATECH / MURACAM B22
SONUS MANILA HEARING CARE CENTER B23
EAR DIAGNOSTICS, INC. B24
ONE PHARMA COMPANY, INC. B25
TAKEDA HEALTHCARE PHILS., INC. B26
ALL-BIO PHARMA, INC. B27
PHAREX HEALTH CORP. B28
RECKITT BENCKISER HEALTHCARE PHILS., INC. B29
GETZ PHARMA PHILS INC. B30
HYPHENS PHARMA PHILIPPINES, INC. B31
PFIZER, INC. B32
WESTMONT PHARMACEUTICALS, INC. B33
CELSUS PHARMACEUTICALS PHILS. INC. B34
BAYER CONSUMER CARE B35 & B36
INTERMED MARKETING PHILS., INC. B37
COMPANY NAME BOOTH NO.
INNOGEN PHARMACEUTICALS, INC. B40
VARIANCE TRADING CORPORATION B41 & B42
RESWERKES B43
ALLMED INSTRUMENTS MEDICAL SYSTEM B44
FAMED B45
DENTSTALL TRADING B46
IOS MARKETING CORPORATION B47 & B48
PINES MEDICAL TRADING B49
MANILA HEARING AID B50
OLTEN INSTRUMENTS PHILS. CORP. B51 & B52
SAVIOUR MEDEVICES, INC. B53
GREAT RECONSTRUCTION SURGICALS, INC. B54
MEDTRONIC PHILIPPINES, INC. B55
COVIDIEN PHILIPPINES, INC. B56
JULLSURG B57
LEFORT MEDICAL TRADING CORP. B58
AMERICAN TECHNOLOGIES INC. B59
PPD/THE FILIPINODOCTOR.COM B60
MICROLAB INC. B61 & B62
BEROVAN MARKETING INC. B63
FERNANDO MEDICAL ENTERPRISES, INC. B64
URGO-VIVA SANTE B38
SENSOMED PHILS., INC. B39